Digestive system disorder
MONDO:0004335A disease or disorder that involves the digestive system.
Also known as: digestive disease, digestive system disease, digestive system disease or disorder, digestive system disorder, disease of digestive system, disease or disorder of digestive system, disorder of digestive system, gastroenterological system disease
15323 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 3816 trials in this tab.
-
Can a Two-Drug combo finally beat chronic hepatitis b?
⭐️ CURE ⭐️ CompletedThis phase 2 trial is testing whether a combination of two experimental drugs, BRII-835 and BRII-179, can clear the hepatitis B virus from the body in adults with chronic infection. Participants will receive the drug combination and then be monitored to see if they can safely sto…
Phase: PHASE2 • Sponsor: Brii Biosciences Limited • Aim: ⭐️ CURE ⭐️
Last updated Jul 25, 2026 00:00 UTC
-
Shorter hepatitis c treatment may be just as effective
⭐️ CURE ⭐️ CompletedThis study tests whether 12 weeks of a three-drug antiviral combination works as well as 24 weeks for curing hepatitis C in people with chronic liver disease. Researchers will enroll 192 patients who have not been treated before and randomly assign them to either the shorter or l…
Phase: NA • Sponsor: Indus Hospital and Health Network • Aim: ⭐️ CURE ⭐️
Last updated Jul 16, 2026 00:00 UTC
-
Can a drinkable vaccine stop Shigella's grip?
⭐️ VACCINE ⭐️ CompletedThis trial tests an experimental oral vaccine, WRSs2, designed to protect against Shigella sonnei, a common cause of severe diarrhea. Healthy adults aged 18-49 receive either the vaccine or a placebo, then are later exposed to the live bacteria in a controlled setting to see if t…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 12, 2026 00:00 UTC
-
New shigella vaccine shows promise for infants in phase 2 trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called Shigella4V2 to protect infants against shigellosis, a severe diarrheal disease. Researchers gave the vaccine to 110 healthy 9-month-old babies to check its safety and how well it triggers an immune response. The goal is to find the best dose…
Phase: PHASE2 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 09, 2026 00:00 UTC
-
Can an arthritis drug boost rectal cancer therapy?
Disease control CompletedThis trial is testing whether adding anakinra, a drug used for arthritis, to standard chemoradiotherapy is safe for people with rectal cancer. The study will include about 12 patients and will use a dose-escalation design to find the highest tolerable dose of capecitabine when co…
Phase: PHASE1 • Sponsor: Goethe University • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Microplastics making you fat? probiotic pill shows promise in new study
Disease control CompletedThis study looked at whether tiny plastic particles (microplastics) we encounter daily might contribute to obesity and gut problems. Researchers gave 96 overweight or obese adults either a probiotic supplement or a placebo to see if the probiotic could reduce the harmful effects …
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Coffee and tea: a new weapon against fatty liver?
Disease control CompletedThis study tests whether adding Turkish coffee or green tea to a Mediterranean diet can reduce liver fat in people with non-alcoholic fatty liver disease (NAFLD). Participants will follow a 12-week diet plan and drink either Turkish coffee twice daily, green tea three times daily…
Phase: NA • Sponsor: Okan University • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Can Mountain-Like workouts help fatty liver? small trial aims to find out
Disease control CompletedThis study tests whether aerobic exercise in simulated altitude (normobaric hypoxia) can improve body composition and metabolism in people with MASLD, a type of fatty liver disease. Twenty sedentary adults with MASLD will walk on a treadmill for 8 weeks, either in mild altitude o…
Phase: NA • Sponsor: University of Trieste • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
New cocktail of three drugs tested for tough bladder cancers
Disease control CompletedThis early-phase trial tested a combination of two chemotherapy drugs (gemcitabine and carboplatin) plus lenalidomide, a drug that blocks blood vessel growth in tumors, in 18 adults with advanced solid tumors, especially urothelial (bladder) cancer. The main goal was to find the …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Can a common spice boost liver health in fatty liver disease?
Disease control CompletedThis trial tests whether adding sumac spice to a calorie-restricted diet can improve liver function and metabolic health in adults with obesity and non-alcoholic fatty liver disease (NAFLD). About 100 participants aged 30-60 will be randomly assigned to take either a placebo or o…
Phase: NA • Sponsor: University of Lahore • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Immune cells supercharged to fight cancer: early trial shows promise
Disease control CompletedThis early-phase trial tested whether giving patients their own natural killer (NK) cells, boosted by the drug bortezomib, is safe for treating advanced cancers like leukemia, lung, and pancreatic cancer. Thirty-five adults whose cancers had not responded to standard treatments r…
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Daily pill could offer new hope for weight loss in east asian adults
Disease control CompletedThis Phase 3 trial is testing whether a once-daily 50 mg semaglutide tablet can help East Asian adults with overweight or obesity lose weight. Participants will take either the active tablet or a placebo for 68 weeks, alongside lifestyle counseling on diet and physical activity. …
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a tree mushroom drink calm inflammatory bowel disease?
Disease control CompletedThis pilot study is testing whether a dietary supplement made from the tinder fungus can safely ease gut symptoms in adults with mild-to-moderate ulcerative colitis or Crohn's disease. Participants will drink the supplement and be monitored for changes in symptoms, inflammation m…
Phase: NA • Sponsor: Good Feeling Products GmbH • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a plasma beam stop anal lesions from becoming cancer?
Disease control CompletedThis phase II trial is testing whether argon plasma coagulation (APC) can safely and effectively treat high-grade anal lesions (AIN 2/3) in HIV-positive men who have sex with men. APC uses ionized argon gas to deliver a controlled electrical current that destroys abnormal cells. …
Phase: PHASE2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could looser blood sugar targets during labor protect babies from low blood sugar?
Disease control CompletedThis study looks at whether allowing a slightly higher blood sugar range (70-110 mg/dL) during labor in mothers with diabetes can reduce the number of newborns with low blood sugar. Researchers will compare this approach to standard care in 169 pregnant women planning a vaginal d…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a higher steroid dose help preterm babies breathe easier?
Disease control CompletedThis study looks at whether a higher dose of dexamethasone, a steroid given to pregnant women at risk of early birth, helps preterm babies' lungs mature better. Researchers are comparing babies born between 26 and 36 weeks whose mothers received either 12 mg or 6 mg of dexamethas…
Sponsor: Stella Maris Women and Children Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Experimental drug targets rare pancreatic cancer in small trial
Disease control CompletedThis phase II trial tested the drug Minnelide in 16 adults with a rare and aggressive form of pancreatic cancer called adenosquamous carcinoma of the pancreas (ASCP) that had not responded to prior treatments. Participants took Minnelide by mouth daily for 21 days of each 28-day …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New combo therapy targets Hard-to-Treat stomach cancer
Disease control CompletedThis early-phase trial is testing whether adding the immunotherapy drug pembrolizumab to standard chemoradiotherapy can help control gastroesophageal cancer that cannot be removed by surgery. The study includes 16 participants and primarily looks at safety and whether the cancer …
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New diabetes pill shows promise in japanese trial
Disease control CompletedThis study tests whether a new tablet formulation of semaglutide (oral semaglutide D) works as well as the approved version in Japanese adults with type 2 diabetes. About 264 participants will take either the new or approved tablet once daily for 27 weeks. Researchers will compar…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can aspirin or diabetes drugs tame fatty liver? new study reveals results
Disease control CompletedThis study looked at whether aspirin or a diabetes drug called an SGLT2 inhibitor (like dapagliflozin) can improve liver health in people with type 2 diabetes and non-alcoholic fatty liver disease. Researchers measured liver enzymes, cholesterol, and liver stiffness (using FibroS…
Phase: NA • Sponsor: Galala University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Seaweed extract may tackle fatty liver Disease—A trial puts it to the test
Disease control CompletedThis study tests whether a supplement made from brown algae and chromium picolinate, when added to a calorie-controlled Mediterranean diet, can reduce fat buildup in the liver. Adults with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic syndrome wil…
Phase: NA • Sponsor: University of Genova • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can delivering cancer drug directly to the liver shrink tumors?
Disease control CompletedThis phase II trial is investigating whether giving the drug bevacizumab directly into the liver's main artery, alongside standard chemotherapy, can shrink liver tumors in people with colorectal cancer that has spread only to the liver. The study enrolls patients whose cancer pro…
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New liver drug safety trial begins for hepatitis b scarring
Disease control CompletedThis study tests a drug called hydronidone in 300 adults with liver scarring (fibrosis or cirrhosis) from chronic hepatitis B. Participants take the drug three times daily for 28 days to see if it is safe. The main goal is to track any side effects.
Phase: PHASE3 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can upadacitinib sustain remission in Crohn's disease?
Disease control CompletedThis study is testing whether upadacitinib, an oral medication, can safely and effectively manage Crohn's disease over the long term. Participants who completed a previous year-long study will continue taking the drug and be monitored for up to a year. The goal is to see if the d…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can an app and cash rewards tame type 1 diabetes in young adults?
Disease control CompletedThis trial tests a digital health program designed to help young adults with type 1 diabetes improve their blood sugar control. Participants use the SweetGoals app to set and track behavioral goals, and some also receive financial incentives for meeting those goals or access to w…
Phase: NA • Sponsor: Trustees of Dartmouth College • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New pill aims to halt liver scarring in hepatitis b and fatty liver patients
Disease control CompletedThis study tests a drug called hydronidone in 200 adults with liver fibrosis caused by chronic hepatitis B or fatty liver disease. Participants take three capsules three times daily for 28 days. The main goal is to check for side effects, not to measure how well the drug works.
Phase: PHASE2 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Which bile duct stone removal method is safer? a large swedish study investigates
Disease control CompletedThis study looks at two techniques for removing common bile duct stones found during gallbladder surgery: placing a temporary stent and doing a follow-up ERCP later, versus doing an ERCP immediately during the same operation. Researchers will compare complications within 30 days,…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New pill aims to tame liver scarring in hepatitis b
Disease control CompletedThis study tests a drug called hydronidone in 150 adults with liver scarring caused by chronic hepatitis B. Participants take the capsules three times daily for 28 days. The main goal is to check for side effects and ensure the drug is safe. This is an early-phase trial, so it fo…
Phase: PHASE2 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New pill for diabetes shows promise in Real-World study
Disease control CompletedThis study will follow about 470 adults with type 2 diabetes who are starting oral semaglutide as part of their normal care. Researchers will track changes in blood sugar (HbA1c) and body weight over 5 to 7 months. The goal is to see how well the medication works when prescribed …
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New diabetes drug shows promise in early trial
Disease control CompletedThis study tested a new medicine called NNC0487-0111 in 448 adults with type 2 diabetes. Participants received either a once-weekly injection, a daily pill, or a placebo for about 43 weeks. The goal was to see how well different doses lower blood sugar and body weight.
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New weekly shot shows promise for diabetes and weight loss
Disease control CompletedThis study tested a new medicine called NNC0519-0130 in 299 adults with type 2 diabetes. The goal was to see if a once-weekly injection can lower blood sugar and body weight. Participants received up to 7 different doses for about 40 weeks. The results will help find the best dos…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a chicory fiber ease toddler constipation?
Disease control CompletedThis trial tests whether a prebiotic fiber from chicory, called fructans, can improve bowel habits in young children aged 1 to 3 with constipation. Half of the 100 participants will receive the prebiotic daily for four weeks, while the other half gets a placebo. Parents will trac…
Phase: NA • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a heart drug tame blood sugar and weight in diabetes?
Disease control CompletedThis phase 2 trial tests whether adding nicorandil, a drug typically used for heart conditions, can improve blood sugar control and reduce body weight in obese people with type 2 diabetes who are already taking sulfonylureas. About 46 adults with a BMI over 30 will receive nicora…
Phase: PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a single pill tackle both fatty liver and diabetes?
Disease control CompletedThis trial tests an experimental oral drug called HTD1801 in adults with nonalcoholic steatohepatitis (NASH), a serious liver condition, along with liver fibrosis and type 2 diabetes or prediabetes. Participants receive either HTD1801 or a placebo to see if the drug can improve l…
Phase: PHASE2 • Sponsor: HighTide Therapeutics (Hong Kong) Limited • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Herbal blend and probiotics: a new hope for stubborn constipation?
Disease control CompletedThis trial tests whether combining a 12-herb traditional Chinese medicine formula with plant-derived probiotics can improve symptoms of slow transit constipation, a condition where the colon moves stool too slowly. About 120 adults with this condition will be randomly assigned to…
Phase: NA • Sponsor: First People's Hospital Of Lin'an District, Hangzhou • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New radiation beads take on standard chemo for liver cancer
Disease control CompletedThis study compares a new treatment called TheraSphere (tiny radioactive beads) to standard chemoembolization for people with liver cancer that cannot be removed by surgery. About 92 Chinese adults with early-to-mid stage liver cancer will be randomly assigned to one of the two t…
Phase: PHASE3 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a new drug combo shrink Hard-to-Treat tumors?
Disease control CompletedThis trial is testing whether an experimental drug called JS015, when combined with standard chemotherapy or immunotherapy, is safe and effective for people with advanced solid tumors that have not responded to prior treatment. The study includes patients with certain cancers lik…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Experimental COM902 drug shows promise in early cancer trial
Disease control CompletedThis early-phase study tested an experimental drug called COM902, alone or with other drugs, in 94 people with advanced cancers like ovarian, lung, and colon cancer. The main goal was to check safety and find the right dose. Researchers also looked for early signs that the drug m…
Phase: PHASE1 • Sponsor: Compugen Ltd • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a stool transplant calm an inflamed pouch?
Disease control CompletedThis study tests whether giving healthy donor stool through an enema once a week for six weeks can help people with active pouchitis—a condition where the surgically created intestinal pouch becomes inflamed. Half the participants receive the real transplant, while the other half…
Phase: PHASE2 • Sponsor: McMaster University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can exercise beat NASH? new trial seeks the perfect dose
Disease control CompletedThis study aims to find the most effective amount of exercise to reduce liver fat in people with NASH, a serious liver disease. Researchers will compare different exercise doses in 45 sedentary adults aged 18-69 with NASH and early-stage liver scarring. The goal is to provide cle…
Phase: NA • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug combo takes on Hard-to-Treat cancers in first human test
Disease control CompletedThis early-stage trial is testing an experimental drug called AMG 355, given alone or together with the immunotherapy Keytruda, in 77 adults with advanced solid tumors (like lung, colon, stomach, or melanoma) that have not responded to standard treatments. The main goals are to c…
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can less radiation be just as good for HPV throat cancer?
Disease control CompletedThis study looks at whether giving less radiation after surgery for HPV-positive throat cancer can still prevent the cancer from coming back while causing fewer long-term side effects. About 83 adults with HPV-positive oropharyngeal cancer will receive either a standard or reduce…
Phase: NA • Sponsor: Indiana University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug aims to calm inflammation in kidney disease patients
Disease control CompletedThis study tested a drug called TOUR006 in 143 adults with chronic kidney disease and high levels of a protein linked to inflammation (hs-CRP). The goal was to see if monthly or quarterly shots could safely lower inflammation. The study is complete, and results will show if the d…
Phase: PHASE2 • Sponsor: Tourmaline Bio, Inc., a Novartis Company • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Smart insulin pump aims to end dangerous nighttime blood sugar swings
Disease control CompletedThis trial tests a smart insulin pump algorithm designed to automatically adjust insulin delivery during the night to keep blood sugar levels in a safe range. The algorithm predicts when blood sugar might drop too low and pauses insulin, and when it might rise too high, it gives …
Phase: NA • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Weekly insulin shot could replace daily jabs for diabetes
Disease control CompletedThis study tested a new insulin called icodec that is injected just once a week, compared to standard daily insulin shots, in over 1,000 adults with type 2 diabetes who had never used insulin before. The goal was to see if the weekly shot controls blood sugar just as well as dail…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Weekly insulin shot could replace daily pokes for diabetes
Disease control CompletedThis study tested a new insulin called icodec that is injected just once a week, compared to the standard daily insulin glargine, in 429 adults with type 2 diabetes. Participants received either the weekly or daily insulin for 6 months. The goal was to see if the weekly shot cont…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can an immunotherapy combo shrink stomach tumors before surgery?
Disease control CompletedThis trial tests whether adding the immunotherapy drug toripalimab to a standard chemotherapy regimen (FLOT) before surgery can improve outcomes for people with locally advanced gastric cancer. Participants receive four cycles of the combination, then undergo surgery, and are fol…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New diabetes drug HTD1801 put to the test in 551-Person trial
Disease control CompletedThis Phase 3 trial tested whether HTD1801 (berberine ursodeoxycholate) can help people with type 2 diabetes who aren't well controlled on metformin alone. Over 500 participants received either the drug or a placebo for 24 weeks. The main goal was to see if the drug lowered blood …
Phase: PHASE3 • Sponsor: Shenzhen HighTide Biopharmaceutical Ltd. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a puff of insulin replace a needle for diabetes?
Disease control CompletedThis trial tests whether inhaled insulin (Exubera) can control blood sugar as well as insulin glargine (Lantus) injections in adults with type 2 diabetes who are not well controlled on two or more oral medications. Participants will receive either inhaled insulin before meals or …
Phase: PHASE4 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a puff of insulin replace a daily shot for diabetes?
Disease control CompletedThis trial tests whether an inhaled form of insulin (Exubera) can control blood sugar as effectively as a daily insulin injection (Lantus) in adults with type 2 diabetes who are not well controlled on two or more oral medications. Participants are randomly assigned to add either …
Phase: PHASE4 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a daily glass of milk help ward off type 2 diabetes?
Disease control CompletedThis trial tests whether eating dairy products can improve how the body uses insulin in overweight and obese adults with prediabetes. Participants will be randomly assigned to eat either limited dairy (1 serving or less per day), reduced-fat dairy, or regular-fat dairy for 12 wee…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Custom hip spacers show promise for infected joints
Disease control CompletedThis study looked at whether a custom-made hip spacer can help people with infected hip replacements. 25 patients had their infected hip implant removed and replaced with a temporary custom spacer, followed by antibiotics. After the infection cleared, they received a new permanen…
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a dental floss loop make polyp removal faster?
Disease control CompletedThis trial tests whether a simple clip-and-floss traction device can speed up the removal of large colon polyps using a technique called endoscopic submucosal dissection (ESD). About 280 people scheduled for ESD will be randomly assigned to receive either the traction device or s…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Smartphone app aims to simplify insulin dosing for type 1 diabetes
Disease control CompletedThis study tests whether a mobile app can help people with type 1 diabetes adjust their insulin doses better than standard care. About 50 participants over age 15 will use the app or receive usual care for 3 months. The main goal is to see if the app improves blood sugar control,…
Phase: NA • Sponsor: University of Baghdad • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a peptide tame type 1 diabetes?
Disease control CompletedThis trial is testing an investigational drug called OPT101 in adults with type 1 diabetes. The goal is to see if it is safe and how it affects the immune system. Participants will receive multiple doses of the drug, and researchers will monitor for side effects and measure drug …
Phase: PHASE1 • Sponsor: Op-T LLC • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Timing of stoma reversal could cut hospital stays
Disease control CompletedThis trial compares two timings for closing a temporary ileostomy after bowel surgery: early (within 8 weeks) versus delayed (after 8 weeks). The goal is to see which approach leads to a shorter post-operative hospital stay. Adults aged 18-65 with a temporary ileostomy scheduled …
Phase: NA • Sponsor: Dr. Waseem Ullah • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a cancer drug stop liver tumors from returning after ablation?
Disease control CompletedThis study is testing whether giving a PD-1 inhibitor (a type of immunotherapy) after microwave ablation can help prevent early-stage liver cancer from coming back. About 200 adults with early liver cancer will receive the drug every three weeks for nine cycles. The main goal is …
Phase: NA • Sponsor: Chen Xiaoping • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New study pits rybelsus against other diabetes pills in Real-World setting
Disease control CompletedThis completed study compared the effectiveness of once-daily oral semaglutide (Rybelsus) to other oral diabetes medications in 1020 adults with type 2 diabetes who were already taking metformin. Participants were randomly assigned to receive either Rybelsus or another diabetes p…
Phase: PHASE4 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Triple therapy aims to boost Cancer-Free survival after surgery for HER2-Positive stomach cancer
Disease control CompletedThis phase II trial tests whether adding pembrolizumab (Keytruda) and trastuzumab (Ontruzant) to standard FLOT chemotherapy, given before and after surgery, can improve outcomes for people with HER2-positive esophagogastric adenocarcinoma. Participants receive the drug combinatio…
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a black seed extract boost immunotherapy against a rare cancer?
Disease control CompletedThis pilot trial is testing whether adding NP-101, a compound from black seed oil, to two immunotherapy drugs (nivolumab and ipilimumab) can help control advanced or metastatic extra-pulmonary neuroendocrine carcinoma (EP-NECA) that has progressed after initial treatment. About 1…
Phase: PHASE1 • Sponsor: Amr Mohamed MD • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
To cut or not to cut: a trial questions routine appendectomy for normal appendices
Disease control CompletedThis study looks at people who undergo laparoscopic surgery for suspected appendicitis but are found to have a normal appendix. It compares two approaches: removing the appendix anyway (routine appendectomy) or leaving it in place. The goal is to see which approach leads to fewer…
Sponsor: Nordsjaellands Hospital • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a traditional herbal remedy tame type 2 diabetes?
Disease control CompletedThis trial investigates whether a traditional herbal drug, NOSHIN SHAHD, can improve insulin resistance and reduce inflammation and oxidative stress in people with type 2 diabetes. Participants will take the herbal drug or a placebo for about six weeks, and researchers will measu…
Phase: PHASE4 • Sponsor: Kerman Medical University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Peer-Led diabetes support shows promise for older black men
Disease control CompletedThis pilot study tests whether having older Black men with diabetes lead support groups can help other older Black men better manage their type 2 diabetes. All 48 participants receive standard diabetes education, and half also get 6 months of monthly peer-led support sessions. Th…
Phase: NA • Sponsor: University of Michigan • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug teduglutide monitored in 250 patients with short bowel syndrome
Disease control CompletedThis study follows 250 people in Japan with short bowel syndrome who are receiving teduglutide (Revestive) injections. Researchers will monitor side effects and how well the drug controls symptoms over 36 months. The goal is to see if teduglutide can safely reduce the need for in…
Sponsor: Takeda • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can surgery offer lasting relief for chronic heartburn? a large registry investigates
Disease control CompletedThis registry follows thousands of adults who undergo laparoscopic surgery for gastroesophageal reflux disease (GERD) or hiatal hernia. It compares two common procedures: fundoplication, which wraps part of the stomach around the esophagus to reinforce the valve, and the LINX dev…
Sponsor: The Heartburn Foundation • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a chat group boost diabetes care in seniors?
Disease control CompletedThis study tests whether a peer-supported self-care program can improve quality of life and diabetes management in adults aged 60 and older with type 2 diabetes. Participants in the intervention group will join weekly video calls with trained peer supporters and receive support v…
Phase: NA • Sponsor: Universiti Putra Malaysia • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a Low-Calorie diet and Weight-Loss drug send type 2 diabetes into remission?
Disease control CompletedThis trial tests whether a 12-week calorie-restricted diet, combined with the weight-management drug Contrave, can help people with type 2 diabetes and obesity achieve remission. Remission means blood sugar levels drop below the diabetes threshold without needing glucose-lowering…
Phase: PHASE4 • Sponsor: Yeouido St. Mary's Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a PET scan spare throat cancer patients from High-Dose radiation?
Disease control CompletedThis trial tests a personalized approach to radiation therapy for people with HPV-related oropharynx cancer. Doctors use PET-CT scans taken before and during treatment to see how well the tumor is responding. If the response is good, the radiation dose is reduced, which may lesse…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a smartphone app tame Alcohol-Related liver disease?
Disease control CompletedThis trial tests whether a digital clinic, delivered through a smartphone app, can improve health outcomes for people with alcohol-associated liver disease (ALD) and alcohol use disorder (AUD). Participants' doctors are randomly assigned to refer them to this digital platform in …
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Glucose monitor may help teens avoid diabetes
Disease control CompletedThis study tests whether wearing a continuous glucose monitor (CGM) alongside lifestyle changes can improve insulin sensitivity in teens aged 10-17 with prediabetes. Fifteen overweight or obese participants will use the Dexcom G7 device to see real-time glucose data, aiming to bo…
Phase: NA • Sponsor: Nemours Children's Clinic • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can two antibodies outsmart metastatic colon cancer?
Disease control CompletedThis trial asks whether adding the antibody drugs bevacizumab and/or cetuximab to standard chemotherapy can help people with metastatic colorectal cancer live longer. Participants receive one of several treatment combinations, and researchers compare overall survival and progress…
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a 16-Hour fast be the key to better blood sugar in teens?
Disease control CompletedThis trial tests whether time-limited eating—consuming all food and drinks within an 8-hour period and fasting for the remaining 16 hours—can improve blood sugar control, insulin function, and body fat in adolescents with type 2 diabetes. Participants aged 12 to 21 will follow th…
Phase: NA • Sponsor: Children's Hospital Los Angeles • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a vaccine boost immunotherapy against a stubborn cancer?
Disease control CompletedThis phase II trial is testing whether a cancer vaccine called PolyPEPI1018, when combined with the immunotherapy drug atezolizumab, can help people with a specific type of metastatic colorectal cancer that has not responded to previous treatments. The study enrolls adults with m…
Phase: PHASE2 • Sponsor: Treos Bio Limited • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
A pocket-sized coach for insulin users? app aims to boost self-care in type 2 diabetes
Disease control CompletedThis study tests a newly developed mobile app designed for adults with type 2 diabetes who are starting insulin for the first time. The app aims to improve how people perceive insulin use and how well they manage their own care. Over one month, participants will use the app and h…
Phase: NA • Sponsor: Ege University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
A tiny stomach tweak may calm reflux after weight-loss surgery — but does it hold up?
Disease control CompletedThis study looks at whether a procedure called endoscopic cardia banding plication (ECBP) can help people who still have severe heartburn and reflux after having a sleeve gastrectomy for obesity. The procedure narrows the opening between the stomach and esophagus using bands, wit…
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug combo aims to shrink rectal tumors before surgery
Disease control CompletedThis early-stage study tests the safety of combining the chemotherapy drug TAS-102 with radiation therapy for people with stage II or III rectal cancer that hasn't been treated yet. The goal is to find the safest dose of TAS-102 to use with radiation before surgery to remove the …
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could dropping gluten tame blood sugar and gut woes in diabetes?
Disease control CompletedThis trial explores whether a gluten-free diet can ease digestive symptoms and improve blood sugar control in people with type 2 diabetes who have non-celiac gluten sensitivity. Participants first follow a gluten-free diet for six weeks. Those who feel better then take part in a …
Phase: NA • Sponsor: National Nutrition and Food Technology Institute • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a milk sugar tame IBD symptoms?
Disease control CompletedThis trial is testing whether a prebiotic supplement called 2'-FL, found in human milk, can safely ease gut symptoms in young people with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. Participants, aged 11 to 25, are in remission and already …
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a simple vitamin cut Post-Transplant infections?
Disease control CompletedThis trial asks whether giving vitamin D3 to people with low vitamin D before a liver transplant can reduce bacterial infections in the first three months after surgery. Adults with cirrhosis and vitamin D deficiency who are scheduled for a liver transplant will receive either we…
Phase: NA • Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Which colonoscopy prep works best for diabetics? new trial aims to find out
Disease control CompletedThis study compares two bowel cleansing solutions, Golytely and SUPREP, for colon cancer screening in people with diabetes. Researchers want to see which one cleans the colon better and is easier to tolerate. About 80 participants will be randomly assigned to one of the two preps…
Phase: PHASE4 • Sponsor: Eisenhower Army Medical Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New weekly shot shows promise for weight loss in diabetes patients
Disease control CompletedThis study tested a new medicine called survodutide (BI 456906) to see if it helps people with overweight or obesity and type 2 diabetes lose weight. Over 750 adults received either the drug or a placebo injection once a week for about 76 weeks, along with diet and exercise advic…
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Herbal fizz tablets aim to tame type 2 diabetes
Disease control CompletedThis early study tests a herbal effervescent tablet taken twice daily before meals in 14 adults with type 2 diabetes. The goal is to see if it safely helps lower blood sugar levels (HbA1c, fasting, and after meals). Participants include those managing diabetes with diet or supple…
Phase: NA • Sponsor: NovoBliss Research Pvt Ltd • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could common diabetes drugs reverse early memory loss?
Disease control CompletedThis study tests whether three diabetes medications—liraglutide, empagliflozin, and linagliptin—can help reverse mild cognitive impairment (early memory and thinking problems) in people with type 2 diabetes. About 396 participants will take one of the drugs for 48 weeks, with an …
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a new suppository bring remission to ulcerative proctitis?
Disease control CompletedThis phase 3 trial is testing whether a hydrocortisone acetate suppository, given once or twice daily, can safely and effectively treat ulcerative proctitis, a form of ulcerative colitis limited to the rectum. About 200 adults with active disease will receive either the active su…
Phase: PHASE3 • Sponsor: Cristcot HCA LLC • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Shock therapy for diabetes: could zapping the gut end insulin shots?
Disease control CompletedThis study tests a new procedure called ReCET that uses gentle electrical pulses to regenerate the lining of the small intestine. Combined with a diabetes drug (semaglutide), the goal is to help people with type 2 diabetes stop using insulin. The study involves 32 adults and comp…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can an old malaria drug boost Radiation's power against pancreatic cancer?
Disease control CompletedThis phase 2 trial is testing whether adding hydroxychloroquine to standard radiation and chemotherapy before surgery can better control pancreatic cancer. About 50 people with resectable pancreatic cancer will receive either proton or photon radiation along with capecitabine and…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a palm oil rival olive Oil's heart benefits?
Disease control CompletedThis trial asks whether cooking with refined high-oleic palm oil can improve cholesterol and blood sugar levels as effectively as olive oil. Healthy adults will be randomly assigned to use one of the two oils in their daily cooking for four months. Researchers will measure change…
Phase: NA • Sponsor: Ruby Alejandra Villamil • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a Cancer-Fighting virus shrink tumors when chemo fails?
Disease control CompletedThis trial tests an experimental virus-based therapy called JX-594 (Pexa-Vec) in people with advanced colorectal cancer that has not responded to standard treatments. The virus is designed to infect and kill cancer cells while also stimulating the immune system. It is given alone…
Phase: PHASE1, PHASE2 • Sponsor: Jennerex Biotherapeutics • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Kentucky study enlists families to fight diabetes together
Disease control CompletedThis study looks at whether involving family members can help people with type 2 diabetes in rural Kentucky eat healthier and exercise more. Researchers will work with 75 participants and their families to create a personalized nutrition and physical activity plan for 6 months. T…
Phase: NA • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a smart pen take the guesswork out of insulin dosing?
Disease control CompletedThis trial tests whether a smart insulin pen called DIA:CONN P8 can help people with type 1, type 2, or pancreatogenic diabetes better control their blood sugar. Participants use the pen for 12 weeks, and the pen automatically calculates bolus insulin doses based on meal informat…
Phase: NA • Sponsor: G2e Co., Ltd • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Glow-in-the-Dark clip could make colon cancer surgery safer
Disease control CompletedThis study tests a new fluorescent clip that glows under special light to help surgeons locate colon tumors during minimally invasive surgery. About 110 adults with colon cancer will be randomly assigned to receive either the clip or a standard dye injection before surgery. The g…
Phase: PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New drug combo shows promise for rare liver disease in early trial
Disease control CompletedThis early-phase study tested whether adding fenofibrate to standard treatment (ursodeoxycholic acid) helps people newly diagnosed with primary biliary cholangitis, a chronic liver disease. Thirty adults participated to see if the combination could normalize liver enzyme levels a…
Phase: EARLY_PHASE1 • Sponsor: Han Ying • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a biologic drug tame Crohn's without steroids? a large Real-World study investigates
Disease control CompletedThis study follows about 600 adults with Crohn's disease who are receiving ustekinumab (Stelara) as part of their routine care. The goal is to see how many achieve steroid-free remission after one year, using a standard symptom score. By including patients from both large researc…
Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Prescribing food: could a diet of medically tailored meals tame diabetes?
Disease control CompletedThis trial tests whether a 'food as medicine' program can help people with diabetes better control their blood sugar. Participants receive weekly medically tailored meals, nutrition classes led by dietitians, and vouchers for fresh produce. The study will measure changes in HbA1c…
Phase: NA • Sponsor: Indiana University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can tighter blood pressure control save hearts in diabetes? massive trial aims to find out
Disease control CompletedThis large study is testing whether a lower blood pressure target can reduce major heart problems like heart attacks, strokes, and heart failure in people with type 2 diabetes. About 9,500 participants with high blood pressure and high cardiovascular risk are being randomly assig…
Phase: NA • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a simple belly press make liver cancer radiation more precise?
Disease control CompletedThis trial is testing a new abdominal compression technique to reduce breathing-related movement of liver tumors during radiation therapy. The study will compare this novel method with current compression devices and traditional thermoplastic masks in 120 adults receiving radiati…
Sponsor: Southern Medical University, China • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Hepatitis b patients may be able to ditch daily pills, new trial hopes
Disease control CompletedThis study tests whether adults with chronic hepatitis B who have no liver scarring can safely stop taking antiviral drugs. The 140 participants have undetectable virus levels and negative HBeAg status. Researchers will monitor for viral relapse and liver problems over time.
Phase: PHASE4 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Immune drug plus targeted chemo shows promise for liver cancer in early trial
Disease control CompletedThis early-phase study tests whether combining the immune-boosting drug nivolumab with a procedure that delivers chemotherapy directly to liver tumors (called deb-TACE) is safe for people with advanced liver cancer. Twenty participants will receive the combination, and researcher…
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a targeted antibody give pancreatic cancer chemo a boost?
Disease control CompletedThis trial is testing whether adding an experimental antibody called XB2001 to a standard chemotherapy regimen can help people with advanced pancreatic cancer. The study has two parts: first, it finds the safest dose of XB2001, then it compares the antibody plus chemo against a p…
Phase: PHASE1, PHASE2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a Team-Based approach curb alcohol use in liver disease?
Disease control CompletedThis pilot study tests whether a coordinated care program can help people with alcohol-related liver disease access addiction and mental health services more easily. The program brings together liver specialists, addiction medicine, and psychiatry to streamline referrals and care…
Phase: NA • Sponsor: University of Manitoba • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
One surgery, two problems? a new approach to pelvic floor repair
Disease control CompletedThis trial investigates whether combining two laparoscopic procedures—resection rectopexy and sacrocolpopexy—can safely and effectively treat women who have both pelvic organ prolapse and obstructive defecation syndrome (a type of chronic constipation). The study will enroll 35 w…
Sponsor: Evangelisches Klinikum Köln Weyertal gGmbH • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New cocktail approach aims to wipe out High-Risk rectal cancer without surgery
Disease control CompletedThis phase 2 trial tests a powerful mix of short-course radiation, chemotherapy (mFOLFOX6), an immunotherapy (PD-1 antibody), and a targeted drug (cetuximab or bevacizumab, depending on genetic markers) in people with high-risk rectal cancer that is mismatch repair proficient (pM…
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New diabetes pill takes on popular drug in Head-to-Head trial
Disease control CompletedThis study tested a new drug called HTD1801 (berberine ursodeoxycholate) against the standard diabetes drug dapagliflozin in 367 adults with type 2 diabetes whose blood sugar was not well controlled by metformin alone. The main goal was to see how well HTD1801 lowers blood sugar …
Phase: PHASE3 • Sponsor: Shenzhen HighTide Biopharmaceutical Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could Weight-Loss surgery slash heart risks in diabetes?
Disease control CompletedThis study looks at whether bariatric (weight-loss) surgery can reduce the risk of heart attacks, strokes, heart failure, and death in people who have both type 2 diabetes and obesity. It compares people who had the surgery with those who received usual diabetes care. The goal is…
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug aims to control blood sugar in kids with rare condition
Disease control CompletedThis study is testing the long-term safety of dasiglucagon, a drug given as a continuous injection under the skin, in children with congenital hyperinsulinism (a condition causing dangerously low blood sugar). The trial includes 42 children who completed earlier studies. Research…
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New pill could help millions with uncontrolled diabetes
Disease control CompletedThis Phase 3 trial tested whether HTD1801, a new drug made from a modified natural compound, can lower blood sugar in people with type 2 diabetes who struggle to control it with diet and exercise alone. The study enrolled 408 adults and compared the drug to a placebo over 24 week…
Phase: PHASE3 • Sponsor: Shenzhen HighTide Biopharmaceutical Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a pain block ease lung strain in severe pancreatitis?
Disease control CompletedThis trial tests whether epidural analgesia—pain medicine delivered near the spinal cord—can help people with severe acute pancreatitis breathe better and avoid needing a breathing machine. About 148 ICU patients with severe pancreatitis will be randomly assigned to receive eithe…
Phase: PHASE3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Growth factor plug aims to heal stubborn anal fistulas
Disease control CompletedThis study tests whether a collagen plug soaked with a lab-made growth factor (rhPDGF-BB) can safely help heal complex anal fistulas—abnormal tunnels between the rectum and skin. The plug is implanted during a procedure, and the growth factor is meant to boost tissue repair. The …
Phase: PHASE2 • Sponsor: Alexander Hawkins • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Gamifying exercise: could a phone app outperform traditional programs for obesity and diabetes?
Disease control CompletedThis trial tests whether a smartphone app called Kiplin, which uses games, telecoaching, and social support, can increase daily physical activity in people with obesity or type 2 diabetes. It compares the app to a standard three-month face-to-face exercise program. The main goal …
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New combo therapy shows promise for Tough-to-Treat head and neck cancer
Disease control CompletedThis study tested whether giving the immunotherapy drug durvalumab alongside radiation works better than the standard cetuximab plus radiation for people with advanced head and neck cancer who cannot take the usual chemotherapy drug cisplatin. A total of 196 adults took part. The…
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a new pill tame blood sugar in type 2 diabetes?
Disease control CompletedThis clinical trial is testing an investigational drug called HTD1801 (berberine ursodeoxycholate) to see if it can improve blood sugar control in adults with type 2 diabetes that is not well managed by diet and exercise alone. The study will compare the drug against a placebo ov…
Phase: PHASE2 • Sponsor: Shenzhen HighTide Biopharmaceutical Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a blood vessel blocker boost esophageal cancer treatment?
Disease control CompletedThis phase 2 trial tests whether adding the drug apatinib to standard chemotherapy and radiation helps people with advanced esophageal cancer that cannot be removed by surgery. About 170 participants will receive either the standard treatment or the standard treatment plus apatin…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a probiotic ease chronic diarrhea? mayo clinic investigates
Disease control CompletedThis study tests whether a high-dose probiotic (De Simone formulation) can lower bile acid levels in stool and improve diarrhea in people with bile acid malabsorption. Twenty-four adults will take the probiotic or a placebo for about three weeks. Researchers will measure changes …
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a daily probiotic capsule tame irritable bowel syndrome?
Disease control CompletedThis trial tests whether an oral probiotic supplement called MetBroma can safely reduce symptoms of irritable bowel syndrome (IBS) and improve quality of life. Adults aged 18 to 60 with an IBS diagnosis will take the probiotic capsule twice a day, and researchers will track chang…
Phase: NA • Sponsor: NovoBliss Research Pvt Ltd • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a gentler iron pill break the anemia cycle in IBD?
Disease control CompletedThis trial tests whether ferric maltol, an oral iron supplement, can safely raise hemoglobin levels in adults with inflammatory bowel disease (IBD) who have iron deficiency anemia and have not responded to or cannot tolerate standard ferrous iron pills. Participants take either f…
Phase: PHASE3 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
A smarter insulin that aims for the liver could curb dangerous nighttime dips
Disease control CompletedThis trial tests whether a specially designed mealtime insulin, HDV-insulin lispro, can reduce nighttime low blood sugar (hypoglycemia) in adults with type 1 diabetes. Participants will use continuous glucose monitors and work with doctors to adjust doses. One group receives the …
Phase: PHASE2 • Sponsor: Diasome Pharmaceuticals • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a glass of pomegranate juice tame gut inflammation?
Disease control CompletedThis trial investigates whether drinking pomegranate juice for 12 weeks can reduce gut inflammation in people with Crohn's disease or ulcerative colitis who are in remission. Participants will drink either pomegranate juice or a placebo beverage twice daily, and researchers will …
Phase: NA • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a new weekly shot beat semaglutide for diabetes control?
Disease control CompletedThis phase 3 trial compares an experimental once-weekly injection, HRS9531, to the established drug semaglutide in adults with type 2 diabetes that is not well controlled by metformin alone or with SGLT2 inhibitors. The study will measure changes in blood sugar levels and body we…
Phase: PHASE3 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Time-Restricted eating: a simple diet hack to reverse prediabetes?
Disease control CompletedThis trial tests whether time-restricted eating (TRE) — limiting all food intake to an 8-10 hour daily window — can improve blood sugar control and metabolic health in people with metabolic syndrome or prediabetes. Participants are randomly assigned to either standard nutritional…
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a Triple-Drug cocktail slow advanced stomach cancer?
Disease control CompletedThis phase 2 trial is testing whether a combination of three FDA-approved drugs—oxaliplatin, capecitabine (Xeloda), and cetuximab—can slow tumor growth in people with advanced or metastatic gastric or gastroesophageal cancer that has not been treated with chemotherapy before. The…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a One-Two punch of heat and drainage tame inoperable bile duct cancer?
Disease control CompletedThis trial is testing a personalized treatment for people with inoperable perihilar cholangiocarcinoma, a type of bile duct cancer. The approach combines radiofrequency ablation — using heat to destroy tumor tissue — with complete drainage of bile ducts, guided by both endoscopy …
Phase: NA • Sponsor: Clinical Hospital Colentina • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Does real-time glucose tracking before surgery cut complications? a massive trial puts it to the test.
Disease control CompletedThis trial tests whether using a continuous glucose monitor (CGM) before and after major surgery can reduce complications in adults with diabetes or impaired glucose tolerance. Participants wear the device for at least 6 hours before surgery and up to 7 days after, while a compar…
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Could a simple exercise program speed healing of diabetic foot ulcers?
Disease control CompletedThis trial tests whether adding supervised exercise to standard care can improve wound healing in people with diabetic foot ulcers. Participants are randomly assigned to aerobic exercise, a structured exercise protocol, or standard care alone for 12 weeks. Researchers track ulcer…
Phase: NA • Sponsor: Harran University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
A drug used during liver surgery may cut the risk of major complications — a study puts it to the test
Disease control CompletedThis study looks at whether giving a drug called terlipressin continuously during keyhole (laparoscopic) liver surgery can lower the chance of severe complications afterward. Terlipressin helps keep blood pressure stable, which may protect organs during surgery. Researchers will …
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
One infusion, two targets: a uric-acid-lowering drug takes aim at heart and kidney disease in youth-onset diabetes
Disease control CompletedThis pilot trial tests whether a single infusion of pegloticase, a drug that breaks down uric acid, can improve markers of heart and kidney health in young men aged 18–25 with youth-onset type 2 diabetes. High uric acid is common in this group and linked to later complications. T…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a weekly shot tame blood sugar and weight in type 2 diabetes?
Disease control CompletedThis trial investigates whether a once-weekly injection of semaglutide can improve blood sugar control and reduce body weight in adults with type 2 diabetes and obesity who have not achieved adequate control with standard therapy. Participants receive semaglutide for 16 weeks, st…
Phase: PHASE4 • Sponsor: Rehman Medical Institute - RMI • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Real-Time text messages from your fitness tracker: a new way to fight diabetes?
Disease control CompletedThis trial tests whether a mobile health system that sends real-time text messages—prompting users to take a walk or stand up after sitting too long—can increase physical activity in people with prediabetes or type 2 diabetes. Participants receive a Fitbit tracker and brief advic…
Phase: NA • Sponsor: Charles University, Czech Republic • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a Brain-Cancer drug take on a stubborn stomach tumor?
Disease control CompletedThis phase 2 trial is testing whether the chemotherapy drug temozolomide can shrink tumors in people with a rare type of gastrointestinal stromal tumor (GIST) that has a mutation in the SDH gene. Standard GIST treatments do not work for this subtype. Participants take temozolomid…
Phase: PHASE2 • Sponsor: Adam Burgoyne, MD, PhD • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Herbal granules take on a stomach condition that raises cancer risk
Disease control CompletedThis trial tests whether Dendrobii granules, a traditional Chinese herbal remedy, can improve chronic atrophic gastritis — a condition where the stomach lining thins and raises the risk of stomach cancer. Twenty adults with the condition will receive either the granules or a plac…
Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
A new heart valve without open surgery? a trial puts it to the test
Disease control CompletedThis trial tests a new replacement heart valve, the Neovasc Tiara, that is delivered through a small tube (catheter) inserted into the chest. It is designed for people with severe mitral regurgitation—a leaky heart valve—who are too high-risk for traditional open-heart surgery. T…
Phase: NA • Sponsor: Shockwave Medical, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can High-Dose vitamin c boost Chemo's punch against pancreatic cancer?
Disease control CompletedThis trial is testing whether adding high-dose vitamin C (ascorbic acid) to a standard three-drug chemotherapy cocktail can safely and effectively control metastatic pancreatic cancer in people who have not yet received any treatment. The study enrolls adults with stage IV pancre…
Phase: PHASE1, PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Bone drugs may double as liver fat fighters — a trial puts them to the test
Disease control CompletedThis trial investigates whether two common osteoporosis medications, denosumab and alendronate, can reduce liver fat and scarring in postmenopausal women who also have nonalcoholic fatty liver disease (NAFLD). The study will compare changes in liver fat and stiffness over 12 mont…
Phase: PHASE4 • Sponsor: Aristotle University Of Thessaloniki • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a simpler chemo schedule tame colorectal cancer with fewer side effects?
Disease control CompletedThis trial tests whether giving the chemotherapy drugs raltitrexed and oxaliplatin every two weeks is as effective and less toxic than the standard every-three-week schedule in people with metastatic colorectal cancer who have not had prior chemotherapy. Some participants also re…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
A sugar syrup may make colonoscopy prep safer and more effective for diabetics
Disease control CompletedThis trial tests whether adding lactulose—a type of sugar syrup—to the standard bowel-cleansing drink (PEG-ELS) can improve colonoscopy preparation in people with type 2 diabetes. Diabetic patients often have poor bowel cleansing, which can reduce the quality of the exam. The stu…
Phase: NA • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can High-Dose vitamin c boost chemo against pancreatic cancer?
Disease control CompletedThis phase II trial tests whether adding high-dose vitamin C (ascorbate) to standard chemotherapy (gemcitabine and nab-paclitaxel) can help people with metastatic pancreatic cancer live longer. About 40 participants are randomly assigned to receive either standard chemo alone or …
Phase: PHASE2 • Sponsor: University of Iowa • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a cancer pill keep working outside the lab? a Real-World test begins
Disease control CompletedThis study monitors the safety and effectiveness of the drug olaparib (Lynparza) in people with ovarian, breast, prostate, or pancreatic cancer who are prescribed it as part of routine care in South Korea. Researchers will track side effects and how long the cancer stays under co…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a supplement melt liver fat? a trial puts it to the test
Disease control CompletedThis trial is testing whether a special supplement containing silibin, glutathione, and vitamin E can reduce fat buildup in the liver and improve liver function in people with MASLD (a common fatty liver disease linked to metabolism). Over 42 adults, each person will take the sup…
Phase: NA • Sponsor: University of Bari • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a new shot help control hepatitis d in people with hepatitis b?
Disease control CompletedThis phase 2 trial is testing whether adding an experimental drug called JNJ-73763989 to standard oral antivirals can better suppress hepatitis D virus in people who are also infected with hepatitis B. About 52 adults with stable chronic co-infection will receive either the combi…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Fig leaf tea may shield kidneys from diabetes damage — a trial puts it to the test
Disease control CompletedThis trial investigates whether drinking fig leaf tea twice a day for 8 weeks, along with a low-glycemic diet, can help protect kidney function in adults with type 2 diabetes and stage 2 chronic kidney disease. Researchers will measure changes in blood sugar, cholesterol, and kid…
Phase: NA • Sponsor: University of Lahore • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
A machine that keeps donor livers alive outside the body — could it transform transplantation?
Disease control CompletedThis trial tests whether a device called VitaSmart, which pumps cold, oxygenated preservation fluid through a donor liver before transplant, can reduce early organ dysfunction and improve survival compared with the usual method of simply storing the liver on ice. About 228 adults…
Phase: NA • Sponsor: Bridge to Life Ltd. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a three-drug cocktail shrink advanced bile-duct tumors?
Disease control CompletedThis phase 2 trial is testing whether combining bevacizumab (a blood-vessel growth blocker) with nab-paclitaxel and an oral chemotherapy called S-1 can shrink tumors in people with advanced biliary tract adenocarcinoma that has worsened after initial treatment. About 32 participa…
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Smart insulin pump may boost brain and body health in older adults with diabetes
Disease control CompletedThis study tests whether an advanced hybrid closed loop insulin pump (MiniMed 780G) can improve blood sugar control, quality of life, thinking skills, and physical abilities in people over 60 with type 1 diabetes. Participants are randomly assigned to either continue their usual …
Phase: NA • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a diet change calm IBD by reshaping gut bacteria?
Disease control CompletedThis study tests whether a specific diet, called the IBD-AID, can improve symptoms of inflammatory bowel disease (IBD) by changing the bacteria in the gut. Participants aged 15 and older with IBD will follow the diet for 8 weeks, with guidance from study staff and cooking classes…
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Experimental drug aims to reverse liver scarring in NASH cirrhosis
Disease control CompletedThis phase 2b trial tests whether efruxifermin, an experimental drug, can improve liver fibrosis (scarring) without worsening inflammation in people with compensated cirrhosis due to NASH. Participants receive either efruxifermin or a placebo for up to 96 weeks. The main goal is …
Phase: PHASE2 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a 5-Day drug course make surgery safer for liver patients with low platelets?
Disease control CompletedThis study tests whether a 5-day course of avatricopal can safely raise platelet counts in people with chronic liver disease who have low platelets and need surgery. The goal is to see if more patients reach a platelet count of at least 50×10⁹/L on the day of their procedure, whi…
Sponsor: Beijing Ditan Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could donating blood help control diabetes and fatty liver?
Disease control CompletedThis study investigates whether reducing iron levels in the body through blood donation can improve insulin sensitivity and liver function in people with type 2 diabetes and non-alcoholic fatty liver disease. Participants will undergo phlebotomy until their iron stores are deplet…
Phase: NA • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Smartphone app could improve blood sugar control in type 2 diabetes
Disease control CompletedThis study tests whether a connected smartphone app called Health2Sync helps adults with type 2 diabetes who use basal insulin achieve better blood sugar control. The app syncs blood glucose readings and shares them with doctors, who can then adjust insulin doses. Researchers com…
Phase: NA • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Four-Drug cocktail aims to shrink pancreatic tumors before surgery
Disease control CompletedThis phase II trial tests whether a combination of four chemotherapy drugs—paclitaxel protein bound, gemcitabine, cisplatin, and hydroxychloroquine—given before surgery can improve outcomes for people with pancreatic cancer that has not spread. The study focuses on patients whose…
Phase: PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Drug combo before and after surgery could boost liver cancer outcomes
Disease control CompletedThis study investigates whether combining two drugs—camrelizumab (an immunotherapy) and apatinib (a targeted therapy)—before and after surgery can improve outcomes for people with liver cancer that can be surgically removed. Participants receive the drug combination before surger…
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can fish oil shrink a fatty liver?
Disease control CompletedThis study tests whether taking omega-3 fatty acid supplements (fish oil) can reduce the amount of fat in the liver of people with nonalcoholic fatty liver disease. Participants take either fish oil or a placebo oil (safflower oil) daily for a period of time. The main goal is to …
Phase: NA • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a slightly lower threshold for treating low blood sugar prevent dangerous spikes in kids with diabetes?
Disease control CompletedThis study tests whether treating low blood sugar (hypoglycemia) at a slightly lower threshold of 65 mg/dL, instead of the standard 70 mg/dL, can prevent rebound high blood sugar in children with type 1 diabetes. Each child undergoes both approaches in a crossover design, receivi…
Phase: NA • Sponsor: Marmara University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Carb showdown: which diet best controls type 1 diabetes?
Disease control CompletedThis study tests how different amounts of dietary carbohydrates affect insulin needs and blood sugar control in adults with type 1 diabetes. Participants are randomly assigned to one of three diets: a traditional diet with 50-60% of calories from carbs, a moderately low-carb diet…
Phase: NA • Sponsor: Anneli Björklund • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New oral drug targets Cancer's growth engine in advanced tumours
Disease control CompletedThis trial investigates an experimental oral drug, LY3143921 hydrate, which blocks a protein called Cdc7 that cancer cells need to divide. It is being tested in adults with advanced solid tumours, including colorectal, ovarian, lung, and pancreatic cancers, that have not responde…
Phase: PHASE1 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a radiofrequency knife beat the stapler for safer pancreas surgery?
Disease control CompletedThis trial tests whether using a radiofrequency device to cut the pancreas during distal pancreatectomy reduces the chance of a pancreatic fistula (a leak of digestive fluids) compared to the standard stapler method. About 112 adults having this surgery for benign or malignant tu…
Phase: NA • Sponsor: Patricia Sanchez Velazquez • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Drug cocktail aims to shrink Hard-to-Treat stomach cancers
Disease control CompletedThis phase 2 trial tests whether combining two drugs—cabozantinib and pembrolizumab—can slow or stop the growth of advanced gastric or gastroesophageal cancer. The study enrolls people whose cancer has worsened despite at least one prior chemotherapy treatment. Researchers will m…
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Ancient herbal combo could speed healing in pancreatitis
Disease control CompletedThis study tests whether adding a traditional Chinese herbal enema (Tongfu Qinghua Decoction) and an external herbal powder (Ruyi Jinhuang Powder) to standard medical care can help adults with acute pancreatitis recover faster. The trial enrolled 100 people aged 18 to 75 with the…
Phase: NA • Sponsor: The Third Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Structured diabetes program aims to help patients take control of blood sugar
Disease control CompletedThis study tests whether a structured Diabetes Healthcare Program can help adults with type 2 diabetes improve their blood sugar control and feel more confident managing their condition. Participants attend six biweekly training sessions covering diet, exercise, medication, and s…
Phase: NA • Sponsor: Health Services Academy, Islamabad, Pakistan • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a 12-Week exercise program boost brain and body health in older adults with diabetes?
Disease control CompletedThis study investigates whether a 12-week program combining aerobic and resistance exercise can improve blood sugar control and cognitive function in adults aged 65-79 with type 2 diabetes and mild memory issues. Participants follow a supervised exercise routine that gradually in…
Phase: NA • Sponsor: Harbin Sport University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a peer coach help young people take control of their chronic illness?
Disease control CompletedThis study tests whether a peer coaching program delivered by phone and text can help adolescents and young adults (ages 16–22) with chronic conditions like sickle cell disease, diabetes, or cystic fibrosis improve their self-management skills. Participants are paired with a trai…
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Pharmacy-Based hepatitis c testing could cure more people on opioid therapy
Disease control CompletedThis study tests whether offering hepatitis C testing right in community pharmacies—using a simple finger-prick device—helps more people on opioid therapy get diagnosed and cured compared to the usual approach of referring them to a clinic. Participants are adults on stable metha…
Phase: NA • Sponsor: University of Dundee • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a pharmacist check-in boost medication adherence in diabetes and kidney disease?
Disease control CompletedThis study tests a support program for people with type 2 diabetes and chronic kidney failure who struggle to take their medications regularly. Participants receive an electronic pill bottle that tracks when they open it, plus short motivational interviews with a pharmacist. The …
Phase: NA • Sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could vinegar and fasting fix prediabetes cholesterol?
Disease control CompletedThis study tests whether taking date cider vinegar daily, alone or combined with 5:2 intermittent fasting, can improve cholesterol and other metabolic measures in adults with prediabetes and mild to moderate high cholesterol or blood pressure. Participants are randomly assigned t…
Phase: NA • Sponsor: University of Lahore • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can simple insoles or special exercises restore balance in diabetic nerve damage?
Disease control CompletedThis study tests two approaches to help people with diabetic neuropathy improve their balance. One group uses textured insoles in their shoes, while the other group does a series of quick stretches and compressions called Rood's facilitatory technique. Both groups also receive co…
Phase: NA • Sponsor: University of Faisalabad • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New oral diabetes drug shows promise in early safety trial
Disease control CompletedThis study tests an experimental oral drug called LY3502970 in Japanese adults with type 2 diabetes. The main goal is to check for side effects and see how the body processes the drug. Participants take either the drug or a placebo and are monitored over up to 24 weeks with blood…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could conscious sedation replace general anesthesia for gallbladder drainage?
Disease control CompletedThis study tests whether endoscopic ultrasound-guided gallbladder drainage can be safely performed using conscious sedation given by the endoscopist, instead of deep sedation or general anesthesia. The trial enrolls elderly, high-risk patients with acute cholecystitis who are not…
Sponsor: Azienda Unita Sanitaria Locale di Piacenza • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Herbal tablet aims to calm IBS-Related diarrhea and pain
Disease control CompletedThis trial tests whether the Chinese herbal tablet Changyanning can reduce diarrhea and abdominal pain in people with diarrhea-predominant irritable bowel syndrome (IBS-D). About 240 adults aged 18 to 65 with moderate to severe symptoms will receive either the herbal tablet or a …
Phase: PHASE4 • Sponsor: Mei Han • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Virus hunts liver tumors before chemo strikes
Disease control CompletedThis study tests a cancer-killing virus called JX-594 (Pexa-Vec) in people with advanced liver cancer that cannot be removed by surgery. Participants receive the virus through an IV and then directly into liver tumors, followed by the standard drug sorafenib. The goal is to see i…
Phase: PHASE2 • Sponsor: Jennerex Biotherapeutics • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Hospital care model aims to treat opioid addiction and serious infections together
Disease control CompletedThis study tests a care model where hospitalized adults with opioid use disorder and a serious infection receive long-acting injectable buprenorphine from their infectious disease doctors, alongside infection treatment. The goal is to keep patients on effective medication for opi…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New injectable drug aims to tame blood sugar in type 2 diabetes
Disease control CompletedThis phase 3 trial tests whether an experimental injectable drug called HRS9531 can help adults with type 2 diabetes achieve better blood sugar control when diet and exercise alone are not enough. Participants receive either HRS9531 or a placebo for 36 weeks. The main goal is to …
Phase: PHASE3 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Immunotherapy combo aims to outperform standard care in advanced liver cancer
Disease control CompletedThis phase 3 trial compares a combination of two drugs—toripalimab (an immunotherapy) and bevacizumab (an anti-angiogenic agent)—against the standard drug sorafenib as the first treatment for people with advanced liver cancer that cannot be surgically removed. The study enrolls a…
Phase: PHASE3 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could rerouting the gut and cutting nerves free people from diabetes drugs?
Disease control CompletedThis trial investigates a surgical procedure for people with type 2 diabetes and mild obesity (grade 1). The surgery combines three steps: rerouting part of the small intestine, reducing the stomach size, and cutting certain abdominal nerves. The goal is to see if this approach c…
Phase: NA • Sponsor: Universidade Positivo • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Ancient grain, modern hope: foxtail millet muffins may tame blood sugar in obesity
Disease control CompletedThis study investigates whether adding foxtail millet muffins to the diet can help manage blood sugar and improve metabolic health in obese adults with type 2 diabetes. Over 10 weeks, participants eat either a wheat muffin or one or two foxtail millet muffins daily, alongside a l…
Phase: NA • Sponsor: University of Lahore • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could two kidney drugs together be better than one?
Disease control CompletedThis study investigates whether taking two medications—finerenone and empagliflozin—together can better slow kidney function decline in people with chronic kidney disease and type 2 diabetes compared to taking either drug alone. Participants are randomly assigned to receive the c…
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Low-carb diet may help type 1 diabetes patients keep making some insulin
Disease control CompletedThis study tests whether a low-carbohydrate diet (under 75 grams per day) can help adults with type 1 diabetes preserve their remaining insulin production. The idea is that the diet might calm the immune attack on insulin-making cells. Participants will follow the diet for a peri…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a single infusion of 'Trainer' cells free liver transplant patients from lifelong drugs?
Disease control CompletedThis study tests whether a single infusion of donor-derived regulatory dendritic cells (DCreg) can help living donor liver transplant recipients safely stop taking immunosuppression drugs. Participants are low-risk patients who are 1 to 3 years post-transplant. They receive the D…
Phase: PHASE1, PHASE2 • Sponsor: Angus W. Thomson PhD DSc • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Two-Drug cocktail aims to tame stubborn Crohn's disease
Disease control CompletedThis study looks at whether combining two drugs—upadacitinib and ustekinumab—at lower doses can help people with Crohn's disease that hasn't improved with standard treatments. Participants are adults aged 18 to 65 who have already tried and failed other therapies. The goal is to …
Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Which surgery for appendicitis has fewer complications?
Disease control CompletedThis trial compares two common ways to remove an inflamed appendix: open surgery (one larger cut) and laparoscopic surgery (several small cuts). The goal is to see which approach leads to fewer complications after the operation. About 832 people with acute appendicitis are taking…
Phase: NA • Sponsor: Zagazig University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control CompletedThis trial investigates a type of immunotherapy called CAR-T cells that are designed to recognize and attack cancer cells carrying a protein called CEA. The study includes adults with advanced gastric, colon, rectal, esophageal, or pancreatic cancer who have not responded to at l…
Phase: PHASE1, PHASE2 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a four-week program boost diabetes tech use in teens?
Disease control CompletedThis study tests a four-week virtual program designed to help teens aged 12-21 with type 1 diabetes use technology like insulin pumps and continuous glucose monitors. Participants complete surveys and interviews about their diabetes management and technology use. The goal is to u…
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Your own plate, tailored just for you: could personalized nutrition beat standard diet advice for diabetes?
Disease control CompletedThis study tests whether a personalized nutrition program—where meals are tailored to each person's calorie needs based on age, sex, weight, height, and activity level—can improve blood sugar, weight, and blood pressure in adults with type 2 diabetes. Participants receive either …
Phase: NA • Sponsor: DINA KEUMALA SARI • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Real-World test of automated insulin system aims to improve blood sugar control for type 1 diabetes
Disease control CompletedThis study tracks 300 adults with type 1 diabetes who use the Omnipod 5, an automated insulin delivery system, as part of their routine care. Researchers will compare blood sugar control—measured by time in target range and HbA1c levels—before starting the system and at 6, 12, an…
Sponsor: Papa Giovanni XXIII Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Smartphone app aims to boost recovery before colon cancer surgery
Disease control CompletedThis pilot study tests a mobile app called PREHapp that guides people through exercises and health tips before colon cancer surgery. The goal is to see if the app is easy to use and whether it helps with recovery, such as walking ability and fewer complications after the operatio…
Sponsor: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Real-World study tests Mirikizumab's power against ulcerative colitis
Disease control CompletedThis study tracks 282 adults with moderate-to-severe ulcerative colitis who are taking mirikizumab as part of their routine care. Researchers will measure how many achieve clinical remission at 12 weeks and endoscopic remission at 24 and 52 weeks, along with changes in symptoms a…
Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Diabetes drug dorzagliatin under Long-Term safety watch
Disease control CompletedThis study tracks the long-term safety of dorzagliatin, a drug for type 2 diabetes, in over 2,000 patients over 52 weeks. Researchers monitor side effects and how well the drug controls blood sugar. The goal is to ensure the drug remains safe for everyday use.
Phase: PHASE4 • Sponsor: Hua Medicine Limited • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can exercise slash heart and diabetes risks in latina breast cancer survivors?
Disease control CompletedThis trial investigates whether a structured exercise program can improve fitness and lower risk factors for heart disease, stroke, and type 2 diabetes in Latina women who have had breast cancer. Participants are randomly assigned to either an 8-month progressive exercise program…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Experimental drug combo aims to shrink inoperable liver tumors
Disease control CompletedThis phase II trial is testing whether a new biologic drug called PM8002, when combined with standard chemotherapy (FOLFOX), can shrink tumors in people with advanced liver cancer that cannot be removed by surgery. The study enrolls about 35 adults with inoperable hepatocellular …
Phase: PHASE2 • Sponsor: Biotheus Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Robotic hip brace may help tame blood sugar spikes after eating
Disease control CompletedThis study tests whether walking with a wearable hip exoskeleton can improve blood sugar control after meals in people with type 2 diabetes. Participants walk for 30 minutes after a meal, either without assistance or wearing the exoskeleton in two different support modes. The goa…
Phase: NA • Sponsor: CHA University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a wearable sensor help young people with type 1 diabetes tame blood sugar swings?
Disease control CompletedThis study tests whether using a continuous glucose monitor (CGM) — a small sensor that tracks blood sugar levels in real time — helps teens and young adults (ages 14 to under 25) with type 1 diabetes improve their blood sugar control compared to standard fingerstick testing. Par…
Phase: PHASE3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
AI takes on IBD colonoscopy: could it outsmart a special light?
Disease control CompletedPeople with inflammatory bowel disease (IBD) have a higher risk of colorectal cancer and need regular colonoscopies to catch early warning signs. This study compares two techniques—narrow-band imaging (a special light) and an artificial intelligence (AI) system—to see which finds…
Phase: NA • Sponsor: Vall d'Hebron Institute Research • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Generic diabetes pill put to the test against Brand-Name drug
Disease control CompletedThis trial compares a generic extended-release tablet containing empagliflozin and metformin to the brand-name Synjardy XR. Healthy adults aged 18 to 45 receive a single dose of each version in random order, and researchers measure drug levels in the blood to see if the generic w…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Free meds and tailored education may cut heart risks in Low-Income seniors
Disease control CompletedThis study tests two strategies in low-income seniors with chronic conditions like heart disease, diabetes, or kidney disease. One group gets free preventive medications (no copayment), and another receives personalized education on medication use and lifestyle. The goal is to se…
Phase: NA • Sponsor: University of Calgary • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Smart sugar sensors may improve recovery from complex pancreatic surgery
Disease control CompletedThis study tests whether using a real-time continuous glucose monitor (RT-CGM) during pancreaticoduodenectomy (a complex surgery) helps keep patients' blood sugar in a safe range and improves recovery. About 246 adults scheduled for this surgery will be randomly assigned to stand…
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Lab-Made immune protein takes on advanced cancers in first human test
Disease control CompletedThis study tests a new drug called pegilodecakin, a lab-made version of a natural immune protein (interleukin-10), in people with advanced solid tumors such as melanoma, lung, breast, prostate, ovarian, kidney, colorectal, and pancreatic cancers. The drug is given as a daily shot…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can cooking classes and exercise outperform medically tailored groceries for heart and kidney health?
Disease control CompletedThis study tests whether a 3-month community program combining nutrition education, cooking classes, and exercise can improve health outcomes for people with Cardiovascular Kidney Metabolic (CKM) syndrome—a cluster of conditions including diabetes, high blood pressure, high chole…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Immunotherapy combo aims to shrink advanced liver tumors
Disease control CompletedThis phase 2 trial investigates whether combining toripalimab (an immunotherapy) with bevacizumab (a drug that cuts off tumor blood supply) can safely shrink advanced liver cancer when used as the first treatment. About 50 to 60 adults with intermediate or late-stage liver cancer…
Phase: PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control CompletedThis early-stage trial tests a new type of cell therapy called CEA-targeted CAR-T for people with advanced colorectal, esophageal, stomach, or pancreatic cancers that have stopped responding to standard treatments. The therapy involves taking a patient's own immune cells, enginee…
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Generic combo diabetes pill could offer cheaper alternative to Brand-Name drug
Disease control CompletedThis trial compares a generic extended-release tablet containing three diabetes drugs (empagliflozin, linagliptin, and metformin) to the brand-name Trijardy XR. The study involves 36 healthy adults who take a single dose of each version under fed conditions to see if the generic …
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Heart showdown: which diabetes drug shields the heart better?
Disease control CompletedThis large phase 3 trial compares two injectable diabetes medications, tirzepatide and dulaglutide, to see which one better prevents major heart problems like heart attacks, strokes, or death from cardiovascular causes. The study includes over 13,000 adults aged 40 and older with…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Generic diabetes drug candidate put to the test in healthy volunteers
Disease control CompletedThis trial investigates whether a generic tablet containing imeglimin hydrochloride works the same way in the body as the brand-name diabetes drug Twymeeg. Healthy adults aged 18 to 45 take a single dose of each version under fasting conditions, and researchers compare how much d…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Doctor training could be key to better diabetes control
Disease control CompletedThis study investigates whether giving endocrinologists (diabetes specialists) a one-week intensive training program helps them manage type 2 diabetes more effectively. The training includes a hospital stay experience and hands-on patient management. Researchers will compare bloo…
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Hand exercises may shield nerves from chemo side effects
Disease control CompletedThis study tests whether a special hand therapy program can prevent chemotherapy-induced nerve damage in the hands of people with pancreatic cancer. Participants are randomly assigned to either the hand therapy or traditional occupational therapy. The goal is to see if the hand t…
Phase: NA • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Clip vs stitch: which secures the appendix better in keyhole surgery?
Disease control CompletedThis trial compares two ways to seal the base of the appendix during keyhole surgery: a single surgical clip versus traditional suture ligatures. The goal is to see which method leads to fewer complications, shorter hospital stays, and lower costs. Adults scheduled for laparoscop…
Phase: NA • Sponsor: Universiti Sains Malaysia • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Engineered virus takes on liver cancer when standard treatment fails
Disease control CompletedThis trial investigates whether JX-594 (Pexa-Vec), a virus modified to attack cancer cells and boost the immune system, combined with best supportive care, can help people with advanced liver cancer live longer. The study enrolls adults whose liver cancer has progressed or who co…
Phase: PHASE2 • Sponsor: Jennerex Biotherapeutics • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Virus therapy takes on Drug-Resistant colorectal cancer
Disease control CompletedThis early-phase trial tests a modified virus called JX-594 (Pexa-Vec) in people with advanced colorectal cancer that has not responded to standard treatments. The virus is designed to infect and kill cancer cells while also stimulating the immune system. The main goal is to chec…
Phase: PHASE1 • Sponsor: Jennerex Biotherapeutics • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Smartphone nursing visits could transform diabetes care for teenagers
Disease control CompletedThis study tests whether regular video or phone calls with a nurse (tele-nursing) can help teenagers with type 1 diabetes improve their blood sugar control, feel more confident managing their condition, and reduce anxiety. Participants aged 12–18 receive diabetes education both i…
Phase: NA • Sponsor: University of Yalova • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Diabetes drugs may reverse fatty liver damage in new trial
Disease control CompletedThis study tests whether combining two diabetes drugs—semaglutide and empagliflozin—can reverse liver damage from NASH (a severe form of fatty liver disease) in people with type 2 diabetes. Participants will receive either the combo, empagliflozin alone, or a placebo for 48 weeks…
Phase: PHASE4 • Sponsor: German Diabetes Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New Dual-Action pill aims to tame type 2 diabetes
Disease control CompletedThis study tests an experimental drug, JP-2266, in adults with type 2 diabetes. The drug works by blocking two proteins (SGLT1 and SGLT2) to help lower blood sugar. Participants receive either JP-2266 or a placebo for 12 weeks, and researchers measure changes in HbA1c, a key bloo…
Phase: PHASE2 • Sponsor: Jeil Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Brain-like software upgrade helps insulin pumps outsmart diabetes
Disease control CompletedThis study tests a software upgrade for an automated insulin pump system (Control-IQ) in adults with type 1 diabetes. The upgrade adds an adaptive biobehavioral control module that learns from the user's patterns to improve blood sugar management. Participants use the standard sy…
Phase: NA • Sponsor: Sue Brown • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New diabetes pill PS1 enters first human safety tests
Disease control CompletedThis study tests PS1, a new tablet designed to help control blood sugar in people with type 2 diabetes. It is the first time PS1 is given to humans, so the main goal is to check its safety and how the body handles it. The trial includes healthy volunteers and people with type 2 d…
Phase: PHASE1 • Sponsor: Pharmasaga Co. Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Placenta cells could tame Crohn's inflammation
Disease control CompletedThis trial investigates whether intravenous infusions of cells from the human placenta (PDA001) can reduce inflammation and improve symptoms in adults with moderate-to-severe Crohn's disease. Participants receive either one of three doses of PDA001 or a placebo, and researchers t…
Phase: PHASE2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Early liver shunt may reduce need for repeated fluid drains in ascites patients
Disease control CompletedThis trial compares two approved treatments for ascites (fluid buildup in the belly) caused by portal hypertension. One group receives large-volume paracentesis (draining fluid with a needle) plus albumin infusion, while the other gets an early TIPS procedure, which creates a new…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Which antibiotic works best after a Child's ruptured appendix? a new trial aims to find out
Disease control CompletedThis trial compares two antibiotic regimens given after surgery for a ruptured appendix in children. One group receives piperacillin/tazobactam, the other receives ceftriaxone plus metronidazole. The goal is to see which treatment leads to a shorter hospital stay and fewer compli…
Phase: PHASE2 • Sponsor: McMaster Children's Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Foot flex could tame cholesterol and blood sugar
Disease control CompletedThis study tests whether a simple foot exercise called the soleus pushup can improve cholesterol, blood sugar, and hormone levels in people with thyroid problems, high blood pressure, or diabetes. Participants will perform the exercise, and researchers will measure changes in blo…
Phase: NA • Sponsor: King Abdullah University Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Double immunotherapy plus liver blockade targets eye cancer that spreads
Disease control CompletedThis trial investigates whether combining two immunotherapy drugs (ipilimumab and nivolumab) with a procedure called immunoembolization can help people whose uveal melanoma has spread to the liver. The drugs help the immune system attack cancer cells, while immunoembolization cut…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Coffee after surgery: a simple sip to speed bowel recovery?
Disease control CompletedThis trial investigates whether drinking coffee after laparoscopic hysterectomy helps the bowels start working again sooner and reduces time spent in the hospital. Women who have the surgery are randomly assigned to receive either standard care plus coffee at set times or standar…
Phase: NA • Sponsor: Istanbul Medipol University Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Immunotherapy shot could replace IV drip for advanced head and neck cancer
Disease control CompletedThis phase I study is testing a subcutaneous (under the skin) injection of toripalimab, an immunotherapy drug, for people with advanced nasopharyngeal carcinoma. The trial compares the new injection to the standard intravenous (IV) version, looking at safety, tolerability, and ho…
Phase: PHASE1 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Simple support strategies may help curb hepatitis c in appalachia
Disease control CompletedThis study tests whether offering peer support, small incentives, telehealth visits, or prepaid phones helps people with hepatitis C and substance use disorders get linked to medical care. Participants are adults in Appalachia who have tested positive for hepatitis C and have a h…
Phase: NA • Sponsor: Carilion Clinic • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Swallowable sponge could replace endoscopy for esophagitis monitoring
Disease control CompletedThis study tests a capsule sponge device as a less invasive alternative to endoscopy for checking how well treatment is working in people with eosinophilic esophagitis (a chronic allergic condition of the esophagus). Participants swallow a capsule attached to a string, which expa…
Phase: NA • Sponsor: East and North Hertfordshire NHS Trust • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Radiation before surgery may boost chemo for Stomach-Esophagus cancer
Disease control CompletedThis phase 3 trial tests whether adding radiation to chemotherapy before surgery helps people with a certain type of stomach-esophagus cancer live longer without the disease returning. About 342 adults with locally advanced but potentially removable cancer will receive either che…
Phase: PHASE3 • Sponsor: Universitätsmedizin Mannheim • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Aerobic exercise may tame multiple chronic conditions in postmenopausal women
Disease control CompletedThis study investigates whether 12 weeks of moderate aerobic exercise can improve heart health, metabolism, and menopause symptoms in postmenopausal women who have two or more chronic conditions like high blood pressure and high cholesterol. Participants will exercise three times…
Phase: NA • Sponsor: Federal University of Uberlandia • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Simple stretching program may counteract Diabetes-Related muscle stiffness
Disease control CompletedThis study investigates whether a passive stretching program can reduce muscle and tendon stiffness in people with type 2 diabetes. Diabetes can cause muscles and tendons to become stiffer, making walking harder and increasing energy use. The trial compares stiffness in people wi…
Phase: NA • Sponsor: Universita di Verona • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New PET scan could spot liver cancer sooner
Diagnosis CompletedThis study tested a special PET/MRI scan that uses a radioactive tracer to find liver cancer cells. The goal was to see if this scan can detect liver cancer earlier and more accurately than standard scans. 52 adults with liver cancer took part, and researchers compared the new sc…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
Sound waves vs. scope: a gentler way to spot pouch inflammation?
Diagnosis CompletedThis study tests whether intestinal ultrasound can accurately detect pouchitis—inflammation of the internal pouch created after ulcerative colitis surgery. Adults who have had this surgery will receive an ultrasound, and the results will be compared to the standard pouchoscopy wi…
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
New study aims to find the best way to catch HPV cancers early in HIV patients
Diagnosis CompletedThis study looks at which tests work best to find early signs of HPV-related cancer in the cervix or anus of people living with HIV. About 1,586 participants from Mexico and Puerto Rico will be tested using different methods, including HPV tests and cell samples. The goal is to c…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
Routine blood test could spot silent liver disease
Diagnosis CompletedThis study is testing whether a common blood test, called FIB4, can help find people with advanced liver fibrosis (serious liver scarring) who don't know they have it. About 500 adults aged 18-70 with a high FIB4 result will get a more detailed liver check, including a special ul…
Phase: NA • Sponsor: University Hospital, Angers • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
Could diabetes be silently damaging your hearing?
Diagnosis CompletedThis study investigates whether hearing problems are an under-recognized complication of diabetes. Researchers will screen 172 adults with type 1 or type 2 diabetes using hearing tests and a questionnaire. If a hearing issue is found, a more detailed assessment will be done to de…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
AI eye for colonoscopy: could software catch what doctors miss?
Diagnosis CompletedThis trial evaluates an AI-based software tool designed to assist doctors in interpreting colonoscopy images. Using previously collected images and biopsy results from over a thousand patients, the study checks how accurately the AI classifies colorectal lesions as cancerous, pre…
Sponsor: Ainex Corporation • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
Can AI read tumor slides to outsmart childhood cancer?
Diagnosis CompletedThis trial is testing whether an artificial intelligence (AI) model can accurately diagnose and grade several types of solid tumors that affect children, including neuroblastoma, medulloblastoma, Wilms tumor, hepatoblastoma, and rhabdomyosarcoma. The AI is trained on thousands of…
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
No more tubes? swallowable capsule could revolutionize stomach acid testing
Diagnosis CompletedThis study tests a new, less invasive way to measure stomach acid using a small wireless capsule (SmartPill) that patients swallow. It compares the capsule's accuracy to the standard method, which involves a tube placed through the nose into the stomach. The study includes health…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
Blood test may spot hidden gallbladder cancer in gallstone patients
Diagnosis CompletedThis study looks at whether ten specific substances in the blood can help tell apart patients with gallbladder cancer from those with only gallstone disease. Researchers will measure these markers in a new group of Chilean patients to confirm earlier findings. If the markers prov…
Sponsor: Centre Paul Strauss • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
A new MRI technique could see inside the Liver's metabolism without a biopsy
Diagnosis CompletedThis pilot study is testing whether a specialized MRI technique using hyperpolarized pyruvate can non-invasively detect metabolic changes in the liver that are linked to fatty liver disease. The study will include people with simple fatty liver (NAFL), those with the more advance…
Sponsor: Michael Ohliger, MD PhD • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
A protein from tumors may show up in blood — a trial puts the idea to the test
Diagnosis CompletedThis study investigates whether a protein called FGF19, normally found in the intestine and gallbladder, appears at higher levels in the blood of people with breast or colorectal cancer compared to healthy individuals. Researchers will measure FGF19 and related markers in fasting…
Sponsor: University of Central Florida • Aim: Diagnosis
Last updated Aug 01, 2026 00:00 UTC
-
Three quick endoscopic checks may predict who still has reflux after surgery
Diagnosis CompletedThis study is developing and testing a simple endoscopic classification to predict whether patients still have pathologic acid reflux after anti-reflux surgery (Nissen or Toupet fundoplication). Researchers are evaluating three key features seen during endoscopy—valve position, v…
Sponsor: IRCCS Policlinico S. Donato • Aim: Diagnosis
Last updated Jul 29, 2026 00:00 UTC
-
Can a scan replace the needle? ultrasound and MRI put to the test against liver biopsy for fatty liver disease
Diagnosis CompletedThis study investigates whether non-invasive imaging techniques—ultrasound and MRI—can accurately diagnose non-alcoholic steatohepatitis (NASH) and liver fibrosis in people with fatty liver disease. Currently, a liver biopsy is the gold standard, but it is invasive and carries ri…
Phase: NA • Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Diagnosis
Last updated Jul 26, 2026 00:00 UTC
-
Blood test and CT combo may spare rectal cancer patients a second surgery
Diagnosis CompletedThis study tests whether a combination of serial C-reactive protein blood tests and targeted CT scans can safely identify which rectal cancer patients can skip a temporary ileostomy after laparoscopic low anterior resection. Anastomotic leakage is a serious complication, and a pr…
Phase: NA • Sponsor: Alexandria University • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.
Diagnosis CompletedThis trial tests whether a new hybrid tracer, ICG-99mTc-nanoscan, can replace the standard tracer for sentinel node biopsy in people with penile cancer, melanoma, or oral cancer. The hybrid tracer combines a fluorescent dye with a radioactive marker, potentially allowing surgeons…
Phase: NA • Sponsor: The Netherlands Cancer Institute • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
New ultrasound device could replace costly MRI for liver disease detection
Diagnosis CompletedThis study tests a new ultrasound-based device called the Liver Incytes System to see if it can measure liver stiffness and fat as accurately as MRI and FibroScan. The device uses sound waves to create images of the liver, similar to a traditional ultrasound. Researchers are enro…
Phase: NA • Sponsor: Sonic Incytes • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
Leg raise test may predict acid reflux risk in obese patients before weight-loss surgery
Diagnosis CompletedThis study aims to define normal pressure thresholds during a straight leg raise maneuver in high-resolution manometry to predict acid reflux in obese patients. Researchers will analyze data from 150 obese patients undergoing preoperative assessment for bariatric surgery. The goa…
Sponsor: IRCCS Policlinico S. Donato • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
Which liver biopsy needle delivers the best tissue? a Head-to-Head comparison
Diagnosis CompletedThis study compares different ways to take a liver biopsy in adults with chronic liver disease, cirrhosis, or who have had a liver transplant. The goal is to see which method—traditional percutaneous (through the belly) or endoscopic ultrasound-guided (through the stomach)—provid…
Sponsor: University Hospital Muenster • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?
Diagnosis CompletedThis study tests whether the inferior vena cava (the body's main vein) can serve as a reliable reference point for measuring blood pressure in the liver during an endoscopic ultrasound. Normally, doctors use a hepatic vein for this, but in people with advanced liver scarring, tho…
Sponsor: University Hospital Muenster • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
Food flavors on the breath may reveal hidden liver disease
Diagnosis CompletedThis study explores whether a simple breath test can detect early liver fibrosis in people with non-alcoholic steatohepatitis (NASH). Participants fast overnight, then drink a mixture of food-grade flavor compounds and provide breath samples over 90 minutes. The way the body proc…
Sponsor: Owlstone Ltd • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
Can a plasma beam stop colon polyps from coming back?
Prevention CompletedThis trial tests whether using a technique called hybrid argon plasma coagulation (h-APC) on the edges of the removal site can prevent colon polyps from growing back after endoscopic mucosal resection (EMR). EMR is a standard procedure for removing large polyps, but when polyps a…
Phase: NA • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Prevention
Last updated Aug 16, 2026 00:00 UTC
-
Could a simple hospital test after birth stop diabetes before it starts?
Prevention CompletedThis study tests whether screening women for type 2 diabetes while they are still in the hospital after giving birth can help catch the disease early and prevent it. About 116 women who had gestational diabetes will be randomly assigned to either early testing or usual care. The …
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Prevention
Last updated Aug 16, 2026 00:00 UTC
-
Fresh produce and videos help chinese immigrants prevent diabetes
Prevention CompletedThis study tested a program to prevent type 2 diabetes in Chinese immigrants with prediabetes. Participants received weekly videos on diabetes prevention and fresh, culturally appropriate produce. The goal was to see if this approach could help people lose weight and build health…
Phase: NA • Sponsor: NYU Langone Health • Aim: Prevention
Last updated Aug 14, 2026 00:00 UTC
-
Can everyday drugs shield the liver from Cirrhosis's worst threats?
Prevention CompletedThis clinical trial investigates whether two existing medications, allopurinol and atorvastatin, can help prevent serious complications in people with stable liver cirrhosis. The study will compare these drugs against a placebo to see if they reduce the number of acute decompensa…
Phase: PHASE2, PHASE3 • Sponsor: Tanta University • Aim: Prevention
Last updated Aug 13, 2026 00:00 UTC
-
Lupus drug hydroxychloroquine tested as COVID-19 shield
Prevention CompletedThis completed study looked at whether lupus patients already taking hydroxychloroquine long-term had a lower risk of catching COVID-19 or developing severe symptoms. Researchers compared 552 patients who either took the drug or did not, using blood tests and questionnaires. The …
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Prevention
Last updated Aug 12, 2026 00:00 UTC
-
A shot that could shield healthcare workers from a silent killer
Prevention CompletedThis trial tests whether a three-dose hepatitis B vaccine can protect healthcare workers in Zambia from infection. The vaccine is given at 0, 1, and 6 months, and blood tests measure the immune response. The goal is to see if the vaccine produces protective antibodies and cellula…
Phase: PHASE4 • Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Prevention
Last updated Aug 12, 2026 00:00 UTC
-
One dose, big hope: antibiotic may stop cholera in kids
Prevention CompletedThis trial tests whether giving children a single dose of the antibiotic azithromycin right after a household member tests positive for cholera can prevent them from getting infected. The study enrolls children aged 1 to 15 who share cooking facilities with a cholera patient. Res…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Aug 09, 2026 00:00 UTC
-
Could an extra flu shot shield vulnerable kids?
Prevention CompletedThis trial tests whether giving children with autoimmune diseases (like inflammatory bowel disease or rheumatologic conditions) an extra booster dose of the flu vaccine improves their immune response compared to a single dose. These children take immunosuppressive medications tha…
Phase: PHASE2 • Sponsor: Stony Brook University • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Could a diabetes prevention strategy also fight heart disease and cancer?
Prevention CompletedThis study follows people at high risk for diabetes who previously took part in a program testing intensive lifestyle changes or the drug metformin. The goal is to see if these approaches can prevent or delay diabetes and reduce long-term health problems like heart disease and ca…
Phase: PHASE3 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC
-
Can a simple steroid injection prevent a painful complication of esophageal surgery?
Prevention CompletedAfter endoscopic removal of large, early-stage esophageal tumors, the esophagus can narrow and make swallowing difficult. This trial tests whether injecting a steroid directly into the surgical site works better than taking oral steroids to prevent that narrowing. About 30 people…
Phase: PHASE4 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Prevention
Last updated Jul 26, 2026 00:00 UTC
-
Could a phone call help rural americans beat colon cancer?
Prevention CompletedThis study tests whether a remotely-delivered patient navigation program helps more rural adults complete colonoscopy screening for colorectal cancer. Participants aged 45-75 who are due for a colonoscopy receive either navigation support from a trained lay navigator or an educat…
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jul 17, 2026 00:00 UTC
-
Can light therapy unblock the gut without surgery?
Symptom relief CompletedThis trial investigates whether laser acupuncture, a non-invasive therapy that uses low-intensity light on traditional acupoints, can help people with adhesive small bowel obstruction—a common complication after abdominal surgery where scar tissue blocks the intestine. The study …
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Aug 18, 2026 02:00 UTC
-
Could a gummy boost your gut, glow, and Get-Up-and-Go?
Symptom relief CompletedThis trial is testing whether a daily dietary supplement called MultiMineral 102 Gummies can improve digestive health, energy levels, and skin health. About 35 adults who have recently experienced issues in all three areas will take two gummies each morning for 8 weeks. Participa…
Phase: NA • Sponsor: Clean Nutraceuticals • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Core strength: a new hope for constipation in kids with cerebral palsy?
Symptom relief CompletedThis trial tests whether a structured core stability program can improve abdominal endurance and reduce constipation in wheelchair-bound children with cerebral palsy. Participants, aged 6-12, will be randomly assigned to either the core program or traditional physiotherapy. Over …
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Could a probiotic ease autism symptoms? new study investigates
Symptom relief CompletedThis study tested a probiotic (BB-12 with LGG) in 123 children with autism and stomach problems. The goal was to see if different doses are safe and can improve behavior and gut health. Researchers tracked side effects, behavior changes, and gut bacteria over 56 days of treatment…
Phase: PHASE1, PHASE2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Digital nurse companion: could an app ease the burden of chronic illness?
Symptom relief CompletedThis trial tests a nurse-assisted eHealth program for patients with heart failure or colorectal cancer. After leaving the hospital, participants use a tablet with the MyDignio app to track vital signs and symptoms, and communicate with a nurse navigator. The goal is to see if thi…
Phase: NA • Sponsor: University of Stavanger • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can a targeted nerve block outsmart pancreatic cancer pain?
Symptom relief CompletedThis trial tests whether an ultrasound-guided injection of alcohol and a numbing agent around the celiac ganglia can relieve pain in people newly diagnosed with inoperable pancreatic cancer. Participants receive either the nerve block or a sham procedure, alongside standard pain …
Phase: PHASE3 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can enzyme pills beat the bloat? new study tests a simple fix for IBS sufferers
Symptom relief CompletedThis study tested whether a dietary supplement containing digestive enzymes (Galactol®) could reduce bloating after meals in people with irritable bowel syndrome (IBS). 300 adults were randomly assigned to take the enzyme supplement plus a low-FODMAP diet, or just the diet alone,…
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
New probiotic aims to soothe tummy troubles in overweight adults
Symptom relief CompletedThis study is testing a new probiotic called CLB101TM in healthy but overweight adults who have digestive issues like bloating or stomach pain. The probiotic is designed to produce a natural substance called butyrate, which may help strengthen the gut lining and support immune he…
Phase: NA • Sponsor: ClostraBio Inc. • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Could a low dose of ketamine ease anxiety in pancreatic cancer?
Symptom relief CompletedThis study tests whether a low dose of oral ketamine can safely help with anxiety in people with pancreatic cancer. Twenty participants will receive both ketamine and a placebo at different times to compare effects. The main goal is to see if such a study is even possible, not to…
Phase: EARLY_PHASE1 • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
New anesthesia combo could slash opioid use after hernia surgery
Symptom relief CompletedThis study tested whether a special anesthesia plan using dexmedetomidine and ketamine could reduce the need for opioid painkillers after laparoscopic hiatal hernia repair. Fifty adults having elective surgery were randomly assigned to receive either the opioid-sparing protocol o…
Phase: NA • Sponsor: Endeavor Health • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Could a stick of gum speed recovery after C-Section?
Symptom relief CompletedThis trial tests whether chewing gum in the hours after a cesarean section can help the bowels start working again sooner and improve a woman's comfort and satisfaction with her birth experience. Researchers will compare 66 women who had a C-section under spinal or epidural anest…
Phase: NA • Sponsor: Karabuk University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Could a skin patch ease stomach pain in scleroderma?
Symptom relief CompletedThis pilot study tests whether a transcutaneous electrical nerve stimulation (TENS) device is acceptable and helpful for people with scleroderma who experience gastroparesis symptoms like bloating and distension. Participants use the device for 45 minutes twice daily after meals …
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Could a blood gel speed tooth healing in diabetes?
Symptom relief CompletedThis study tests whether a gel made from a patient's own blood platelets can help diabetic individuals heal faster after tooth removal. Twelve adults with diabetes who need two similar-sized tooth extractions will receive the gel in one socket and standard care in the other. Rese…
Phase: NA • Sponsor: King Abdulaziz University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Could a simple mouthwash protect cancer patients from Radiation's painful side effects?
Symptom relief CompletedThis trial tests whether a mouthwash containing lithium can prevent or reduce oral mucositis (painful mouth sores) and dysgeusia (taste changes) in people receiving radiation for head and neck tumors. Participants will rinse with either a lithium mouthwash or a placebo during the…
Phase: PHASE1, PHASE2 • Sponsor: West China Hospital • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
FitBit coaching may help amputees walk more after surgery
Symptom relief CompletedThis study tests whether a walking program that uses FitBit tracking and personalized coaching can help people who recently had a leg amputation due to diabetes or peripheral artery disease become more physically active. Participants will use a FitBit to monitor their steps and r…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can a Nerve-Blocking procedure outperform painkillers for cancer pain?
Symptom relief CompletedThis study tests whether a CT-guided nerve block called celiac plexus neurolysis can relieve severe abdominal pain in people with upper gastrointestinal cancer better than standard pain medication. About 110 adults with biopsy-proven upper GI cancer and severe pain will be random…
Phase: NA • Sponsor: Mayo Hospital Lahore • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Lidocaine may replace opioids for Post-Surgery pain
Symptom relief CompletedThis study tested whether lidocaine, a common numbing drug, works as well as remifentanil (an opioid) for pain after laparoscopic gallbladder removal. 138 adults took part. The goal is to find effective pain relief with fewer opioid side effects.
Sponsor: Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Popular bloating supplement put to the test in First-Ever clinical trial
Symptom relief CompletedThis study tests whether a popular dietary supplement called Inno Cleanse can reduce bloating in healthy adults who feel bloated often. Researchers will give 30 participants either the supplement or a placebo for two weeks and track changes in bloating, weight, and gut health. Th…
Phase: NA • Sponsor: University of Memphis • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can a digital rehab program help colon cancer patients recover at home?
Symptom relief CompletedThis study tests whether a home-based telerehabilitation program can improve functional capacity and quality of life for patients recovering from colorectal cancer surgery. Fifty-four participants will either follow the digital program or receive a standard booklet. The goal is t…
Phase: NA • Sponsor: Instituto de Investigación Sanitaria Aragón • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Could a phone app help parents of kids with special needs thrive?
Symptom relief CompletedThis trial tests a 12-week smartphone-based program called PACT, which combines acceptance and commitment training with positive parenting advice, for parents of children with special health care needs. The goal is to see if it can improve parents' mental well-being, psychologica…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New combo may ease pain after liver transplant
Symptom relief CompletedThis study tests whether giving methadone and ketamine during a deceased donor liver transplant can lower pain and confusion after surgery. About 50 adults will receive either the drug combo or standard care. Researchers will track pain scores, opioid use, and recovery time.
Phase: PHASE4 • Sponsor: Lahey Clinic • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New recovery plan may get kids home faster after bowel surgery
Symptom relief CompletedThis study tested a 21-step enhanced recovery protocol for children aged 10-18 undergoing elective gastrointestinal surgery. The protocol included things like shorter fasting times, early eating and moving, and less use of opioids. The goal was to see if it could shorten hospital…
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can tiny ear needles unblock Post-Stroke constipation?
Symptom relief CompletedThis trial tests whether auricular acupuncture—using tiny needles on specific ear points—can ease constipation in hospitalized stroke patients. Participants receive either real ear acupuncture or a sham version, alongside standard care, for eight daily sessions. Researchers will …
Phase: NA • Sponsor: Ho Chi Minh City Orthopedics and Rehabilitation Hospital • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can a plant compound help control blood sugar? new study explores Quercetin's effects
Symptom relief CompletedThis study looked at whether quercetin, a natural substance found in foods like apples and onions, can change how the body absorbs sugar. Researchers gave 24 obese adults (some with type 2 diabetes) either quercetin or a placebo during a sugar-drink test. They measured blood suga…
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
A simple card game could transform diabetes care
Symptom relief CompletedThis trial tests a set of conversation cards, called QBSafe, designed to help people with type 2 diabetes talk with their doctors about what matters most in their daily lives. The goal is to see if these conversations can reduce the burden of living with diabetes and improve well…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Can a smartphone app tame acid reflux and restore sleep?
Symptom relief CompletedThis study tests whether a mobile app can help people with gastroesophageal reflux disease (GERD) reduce symptom recurrence and improve sleep quality and quality of life. Participants with confirmed GERD will be randomly assigned to either use the app—which provides education, li…
Phase: NA • Sponsor: Fooyin University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can a capsule calm the Post-Meal stomach blues?
Symptom relief CompletedThis trial tests whether a capsule called Galeo (dihydroxydibutylether) can ease the bloating, fullness, and nausea that some people feel after eating, a condition known as postprandial distress syndrome. About 226 adults with this condition will take either Galeo or a placebo fo…
Phase: PHASE4 • Sponsor: Pusan National University Yangsan Hospital • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can surgery for a bowel disorder also lift depression and anxiety?
Symptom relief CompletedThis study follows 140 people with obstructive defecation syndrome (ODS) — a condition that causes straining and difficulty passing stool — who are scheduled for surgery. Researchers will measure depression and anxiety using standard questionnaires before and after the procedure,…
Sponsor: Evangelisches Klinikum Köln Weyertal gGmbH • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can a targeted nerve block replace opioids after stomach cancer surgery?
Symptom relief CompletedThis trial compares two types of nerve blocks for pain relief after open gastric cancer surgery. The blocks are injected near the abdominal wall to numb the area, potentially reducing the need for opioid painkillers, which can cause side effects like drowsiness and constipation. …
Phase: NA • Sponsor: TC Erciyes University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can a natural supplement soothe an upset stomach?
Symptom relief CompletedThis trial tests whether the dietary supplement Meu-cinn can improve gastric mucosal health and ease symptoms in adults with functional dyspepsia, a condition causing stomach discomfort without a clear cause. Participants will take either Meu-cinn or a placebo daily for 8 weeks. …
Phase: NA • Sponsor: Pusan National University Yangsan Hospital • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Could a Nutrient-Rich diet tame the painful side effects of chemoradiotherapy?
Symptom relief CompletedThis trial tests whether a special liquid nutrition formula, enriched with arginine, omega-3 fatty acids, and nucleotides, can reduce the frequency and severity of mouth sores (mucositis) in patients with head and neck or esophageal cancer undergoing chemoradiotherapy. Participan…
Phase: PHASE4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Can a daily capsule ease bloating and boost energy?
Symptom relief CompletedThis trial tests whether a daily dietary supplement called Edenboost Alpha Cleanse can improve liver health and ease digestive symptoms like bloating, abdominal pain, fatigue, and nausea. Forty adults aged 40 to 65 who have struggled with low energy and at least two digestive iss…
Phase: NA • Sponsor: Edenboost • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Which diet do IBD patients prefer? intermittent fasting, mediterranean, or low FODMAP?
Symptom relief CompletedThis study investigates how easy or hard it is for adults with inflammatory bowel disease (IBD) to follow three different eating plans: intermittent fasting, the Mediterranean diet, and the low FODMAP diet. Researchers will interview participants to understand what helps or hinde…
Phase: NA • Sponsor: McMaster University • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Gut bacteria may hold the key to constipation relief
Symptom relief CompletedThis trial tests whether a daily probiotic called Weizmannia coagulans BC99 can relieve chronic constipation in adults. One hundred participants will receive either the probiotic or a placebo for several weeks. Researchers will measure changes in stool consistency, gut bacteria, …
Phase: NA • Sponsor: Wecare Probiotics Co., Ltd. • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Gut bacteria booster may relieve constipation without drugs
Symptom relief CompletedThis trial tests whether a probiotic called Pediococcus acidilactici PA53 can improve stool consistency, gut bacteria balance, and inflammation in adults with functional constipation. Participants take the probiotic or a placebo daily for 8 weeks. The study measures changes in st…
Phase: NA • Sponsor: Wecare Probiotics Co., Ltd. • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can a daily pill douse the Sun's pain for people with EPP?
Symptom relief CompletedThis phase 2a trial tests whether an experimental oral drug called PORT-77 can lower levels of protoporphyrin IX (PPIX) in the blood of adults with erythropoietic protoporphyria (EPP). People with EPP experience severe pain and skin reactions after even brief sun exposure. The st…
Phase: PHASE2 • Sponsor: Portal Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can removing the catheter early speed up liver surgery recovery?
Symptom relief CompletedThis trial investigates whether removing a urinary catheter within 6 hours after laparoscopic liver surgery, as part of an enhanced recovery program, improves urinary function and reduces complications. About 212 adults aged 18 to 75 with benign or malignant liver tumors schedule…
Phase: NA • Sponsor: Yu Zhang • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can a common laxative beat the standard prep for colon cancer screening?
Symptom relief CompletedThis trial compares two bowel-cleansing agents—lactulose and polyethylene glycol (PEG)—to see which provides a cleaner colon for colonoscopy. About 450 adults aged 18–79 scheduled for a screening colonoscopy will be randomly assigned to one of the two preparations. The study meas…
Phase: PHASE4 • Sponsor: Hospital Civil de Guadalajara • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Cold spray may take the sting out of insulin shots — a trial puts it to the test
Symptom relief CompletedThis trial tests whether a quick cold spray on the skin before a subcutaneous insulin injection can reduce pain compared to a placebo spray. Adults in the emergency department who need at least two insulin injections receive both sprays in random order, rating their pain after ea…
Phase: NA • Sponsor: Abant Izzet Baysal University • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can a simple diet switch calm IBS? a trial puts two popular eating plans to the test.
Symptom relief CompletedThis trial compares two diets—low-FODMAP and lactose- and gluten-free—in adults with irritable bowel syndrome (IBS). Each participant tries both diets for four weeks, with a one-week break in between, to see which one better reduces gut symptoms and improves mental health. The go…
Phase: NA • Sponsor: Antalya Bilim University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Can a pill stop the relentless itch of a liver disease? a major trial aims to find out.
Symptom relief CompletedThis phase 3 trial is testing an experimental drug called linerixibat against a placebo in about 238 adults with primary biliary cholangitis (PBC) who suffer from moderate to severe itching. The goal is to see if linerixibat can reduce itch severity and improve quality of life ov…
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Could a postbiotic soothe irritable bowel syndrome?
Symptom relief CompletedThis study tests whether a daily postbiotic supplement called PosBion® can ease symptoms and improve quality of life in adults with irritable bowel syndrome (IBS). Participants take two sachets of the supplement each day for 12 weeks. Researchers measure changes in IBS symptoms, …
Phase: NA • Sponsor: My Myracle Sdn.Bhd • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Squeeze or screen: simple distractions may tame Kids' enema anxiety
Symptom relief CompletedThis study tests whether using a stress ball or watching a short aquarium video with music can reduce fear, anxiety, and pain in children aged 6 to 12 who need an enema for constipation or bloating in the emergency department. Children are randomly assigned to one of the two dist…
Phase: NA • Sponsor: Manisa Celal Bayar University • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Which painkiller works best before gallbladder surgery?
Symptom relief CompletedThis trial compares two common pain medicines—gabapentin and diclofenac sodium—given before laparoscopic gallbladder removal. The goal is to see which one provides better pain relief after surgery. Sixty adults aged 20 to 60 with chronic gallbladder inflammation are taking part. …
Phase: NA • Sponsor: Sohag University • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Ancient Mind-Body practice tested as fatigue fighter for men after cancer
Symptom relief CompletedThis study investigates whether a 12-week program of tai chi and qigong (called Body Mind Training) can reduce fatigue in male cancer survivors aged 55 and older. Participants are randomly assigned to the mind-body training, a light exercise-only group, or a usual-care group. Res…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Family talk could be key to preventing disease in Mexican-American communities
Knowledge-focused CompletedThis study examined how Mexican-American families discuss their risk for diabetes, heart disease, breast cancer, and colon cancer. Researchers interviewed 498 adults from Mexican-American households in Houston to understand how culture and family history influence health communic…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Mom knows best: using family history to fight disease
Knowledge-focused CompletedThis study looked at whether teaching mothers about their family health history can help them encourage healthier eating and exercise in their families. About 310 adults with at least one child took part. Researchers gave them a Family Health Package with personalized risk info a…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
50,000 iranians join quest to uncover esophageal cancer triggers
Knowledge-focused CompletedThis completed study enrolled over 50,000 adults aged 40-75 in Iran's Golestan Province to understand why esophageal cancer is so common there. Participants filled out lifestyle and diet questionnaires and provided blood, urine, hair, and nail samples. Researchers are analyzing f…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Study explores how race affects diabetes and heart disease risk in women
Knowledge-focused CompletedThis completed study looked at risk factors for diabetes and heart disease in 146 healthy African, African-American, and white women who were federal employees or contractors. Researchers compared things like triglyceride levels and insulin resistance to see if the best screening…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Your iPhone could be your next cancer symptom tracker
Knowledge-focused CompletedThis study tested whether iPhones and Apple Watches can reliably collect health data from people with cancer. 49 adults undergoing cancer treatment wore an Apple Watch and used an iPhone for 4 months to track activity, fatigue, and thinking skills. The goal was to see if these de…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Massive study digs into genetic roots of stomach cancer
Knowledge-focused CompletedThis study collected information from 733 people with a personal or family history of hereditary stomach cancer. The goal was to better understand how these cancers develop and what genes are involved. Participants provided medical history, blood samples, and genetic testing. The…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Blood safety watch: 1,771 transfusion patients tracked for hidden infections
Knowledge-focused CompletedThis study followed 1,771 adults and children who received blood transfusions to check how safe the blood supply is. Researchers tested patients' blood for viruses like HIV and hepatitis before and after transfusion, and stored samples for future testing. The goal was to keep blo…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Blood donors help unlock secrets of hepatitis c
Knowledge-focused CompletedThis study looked at 805 blood donors who tested positive for hepatitis C virus (HCV) to learn how the virus spreads and affects health over time. Researchers collected blood samples and health information to track infection and liver disease. The goal was to better understand HC…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Scientists probe Inflammation's role in heart disease and diabetes
Knowledge-focused CompletedThis completed study looked at how inflammation might connect heart disease and diabetes. Researchers used PET scans and blood tests to measure inflammation in 150 adults, including healthy volunteers. The goal was to better understand these links, not to test a new treatment.
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Can a Two-Week insulin vacation help young diabetics?
Knowledge-focused CompletedThis study looks at how type 2 diabetes affects young people aged 12 to 25. Researchers want to see if giving the pancreas a 2-week rest with insulin shots can improve its ability to make insulin. Participants take metformin, follow a diet, and some also get insulin. The study al…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Scientists hunt for diabetes genes in west africa
Knowledge-focused CompletedThis study looked at the genes and lifestyle of over 7,400 people in Nigeria to understand why some develop type 2 diabetes. Researchers compared people with and without diabetes to find genetic differences. The goal is to learn more about diabetes causes in African populations a…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Could popular diabetes drugs boost cancer survival? new study investigates
Knowledge-focused CompletedThis study analyzed health records of over 200,000 adults with obesity and type 2 diabetes to see if taking GLP-1 drugs (like Ozempic) before a cancer diagnosis is linked to better survival and fewer complications after cancer. The researchers compared GLP-1 users to those on oth…
Sponsor: Chung Shan Medical University • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
HIV cancer study reveals who gets sick and why
Knowledge-focused CompletedThis study looked at 460 people with HIV to see what types of cancer they have and why some choose to join cancer clinical trials. Researchers tracked cancers like Kaposi sarcoma, lymphoma, and HPV-related tumors. They also used surveys to learn how HIV and cancer treatments affe…
Sponsor: AIDS Malignancy Consortium • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Zapping the brain to calm the gut: a new frontier for IBS?
Knowledge-focused CompletedThis study tests whether non-invasive brain stimulation (rTMS) can alter gut activity in healthy people and those with functional dyspepsia or IBS. Researchers will measure stomach rhythms, heart rate, and fullness thresholds after applying rTMS to the motor cortex. It is an earl…
Phase: NA • Sponsor: David Levinthal • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Blood test score may flag High-Risk esophageal surgery patients
Knowledge-focused CompletedThis study looks at whether a simple score calculated from routine blood tests—measuring hemoglobin, albumin, lymphocytes, and platelets (the HALP score)—can help predict complications after surgery to remove esophageal cancer. Researchers will track how this score changes before…
Sponsor: Istanbul Saglik Bilimleri University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New liver Drug's safety check: can it mix with hepatitis b antivirals?
Knowledge-focused CompletedThis early-stage trial will test a new drug called hydronidone, which is being developed for liver fibrosis caused by hepatitis B. Since patients often need to take antiviral drugs for hepatitis B, researchers want to see if hydronidone can be taken safely alongside four common a…
Phase: PHASE1 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Heart safety check for experimental liver drug
Knowledge-focused CompletedThis early-stage trial tested whether a single dose of hydronidone, an experimental drug for liver fibrosis, changes the heart's electrical activity (QTc interval) in 48 healthy Chinese adults. Participants received one of three doses or a placebo, and researchers measured how th…
Phase: PHASE1 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Diabetes may change how fast the stomach empties before surgery
Knowledge-focused CompletedThis study used ultrasound to measure how much fluid remains in the stomach after standard preoperative fasting in 592 adults scheduled for elective surgery. Researchers compared diabetic and non-diabetic patients to see if diabetes affects stomach emptying. The goal is to help t…
Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Liver function and drug processing: a closer look at hydronidone
Knowledge-focused CompletedThis study looks at how the drug hydronidone moves through the body in people with different levels of liver function. Thirty adults with either normal liver function or varying degrees of liver impairment will take a single dose of the drug. The goal is to understand how liver h…
Phase: PHASE1 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Massive Real-World study tracks Atezolizumab's performance in routine cancer care
Knowledge-focused CompletedThis study follows over 2,700 people with bladder, lung, or liver cancer who are receiving the drug atezolizumab as part of their normal treatment. Researchers are tracking how long patients live and how well the drug controls their cancer outside of a controlled clinical trial. …
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Could a stress hormone be behind the hidden danger of low blood sugar?
Knowledge-focused CompletedThis study looks at whether adrenaline, the body's stress hormone, triggers an immune reaction during low blood sugar (hypoglycemia) in people with and without type 1 diabetes. Researchers will lower participants' blood sugar and then give drugs that block adrenaline's effects to…
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Why are more younger adults getting colorectal cancer? a national study digs into the data
Knowledge-focused CompletedThis study examines national data from Switzerland to understand trends in early-onset colorectal cancer, which affects people under 50. By analyzing surgical cases from 2003 to 2022, researchers aim to see how common this cancer is, where it occurs, and what short-term outcomes …
Sponsor: Cantonal Hospital of St. Gallen • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Could a new staging system better predict esophageal cancer outcomes?
Knowledge-focused CompletedThis study analyzed data from 414 esophageal cancer patients who received chemoimmunotherapy before surgery. Researchers developed a new 'bio-anatomical' staging system that combines tumor characteristics and immune response to better predict survival and guide post-surgery treat…
Sponsor: Sichuan University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can a simple nutrient help teens with diabetes?
Knowledge-focused CompletedThis study looks at how the body processes arginine, a natural nutrient, in teenagers with type 2 diabetes. Researchers will give participants arginine and measure its effect on insulin production. The goal is to better understand the disease and see if arginine could be a safe, …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Could a common diabetes drug weaken your bones?
Knowledge-focused CompletedThis study asks whether pioglitazone, a widely used diabetes medication, might reduce bone density in people with type 2 diabetes. Researchers will compare bone mineral density and bone turnover markers in adults aged 30-55 who take pioglitazone versus those who do not. The goal …
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Fake health news: study reveals how online lies harm chronic patients
Knowledge-focused CompletedThis study looks at how false or misleading health information found online affects the way people with chronic illnesses like diabetes and high blood pressure take their medications and make treatment decisions. Researchers will survey 300 adults who use social media at least on…
Sponsor: Alexandria University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
3D-Printed vs. milled splints: which feels better in your mouth?
Knowledge-focused CompletedThis study will test whether 3D-printed or milled occlusal splints are more comfortable and stable for healthy adults. Twenty-four participants will try both types and report how they feel. Dentists will also evaluate the fit. The goal is to learn which method works best for futu…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Could your gut bacteria hold the key to protecting your kidneys?
Knowledge-focused CompletedThis study investigates the link between gut bacteria and diabetic kidney disease, a common complication of type 2 diabetes. Researchers will analyze blood, urine, and stool samples from 556 adults with the condition to look for bacterial and metabolic markers. The goal is to und…
Sponsor: The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can a phone call help cancer survivors get the genetic answers they need?
Knowledge-focused CompletedThis study looked at whether offering genetic counseling by phone or video could help more childhood cancer survivors get genetic testing. About 391 survivors took part, comparing remote counseling to usual care. The goal was to see if remote services increase testing uptake and …
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Bedside tech lessons may boost diabetes care for latino patients
Knowledge-focused CompletedThis study tests whether teaching Latino patients with type 2 diabetes how to use patient portals and telehealth during a hospital stay helps them manage their care after discharge. 84 adults will receive either one-on-one digital training or standard care. The main goal is to se…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Could a peptide injection help rebuild Insulin-Making cells?
Knowledge-focused CompletedThis early-stage trial is testing an experimental drug called HTD4010, a synthetic version of a natural peptide that may help the pancreas regenerate insulin-producing cells. The study enrolls healthy, non-diabetic volunteers to receive single ascending doses of the drug or a pla…
Phase: PHASE1 • Sponsor: HighTide Therapeutics (Hong Kong) Limited • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Could a new molecule tame a rare liver disease? early safety trial begins
Knowledge-focused CompletedThis early-stage trial tests whether a single dose of HTD1801, an experimental drug for primary sclerosing cholangitis, is safe and tolerable in healthy adults. Researchers will monitor participants for side effects and measure how the drug moves through the body. The goal is to …
Phase: PHASE1 • Sponsor: HighTide Therapeutics (Hong Kong) Limited • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Mindfulness may cut colon cancer risk in High-Stress communities
Knowledge-focused CompletedThis pilot study tested whether a mindfulness program could help reduce colorectal cancer risk factors in Black women aged 45-65 who live in high-crime Chicago neighborhoods and have had a colon polyp. Twenty-four women participated to see if the program was feasible and acceptab…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
AI reads scans to forecast Crohn's complications
Knowledge-focused CompletedThis study is testing whether an artificial intelligence system can more accurately classify small bowel Crohn's disease and predict how patients will fare over the next year. Researchers will analyze existing CT or MRI scans from 437 patients, combining imaging features with cli…
Sponsor: Shanghai 10th People's Hospital • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Can extra weight complicate colorectal surgery? a new study investigates
Knowledge-focused CompletedThis study looks at whether obesity, measured by body mass index (BMI), affects the chances of a 'textbook outcome' after minimally invasive surgery for colorectal cancer. A textbook outcome means the surgery went smoothly with no major complications, a short hospital stay, and n…
Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Could a Dairy-Rich diet tame type 2 diabetes?
Knowledge-focused CompletedThis study looks at whether people with type 2 diabetes who eat more dairy products (like milk, cheese, and yogurt) during an intensive lifestyle program have better blood sugar control and weight maintenance. Researchers will track changes in A1C, weight, and cholesterol in abou…
Sponsor: Joslin Diabetes Center • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Gut bacteria may hold clues to anal cancer risk in hispanic HIV patients
Knowledge-focused CompletedThis completed study examined 217 Hispanic people living with HIV in California, Mexico, and Puerto Rico to see if the types of bacteria in the anus are linked to high-risk HPV infection and pre-cancerous lesions. Researchers collected anal swabs and questionnaires to compare mic…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Blood marker may predict IBD Flare-Ups
Knowledge-focused CompletedThis study is looking at whether a substance in the blood called LRG can help doctors tell how active ulcerative colitis or Crohn's disease is in the gut. Researchers will measure LRG levels in 300 people who might have these conditions and compare them with what is seen during a…
Sponsor: Showa Inan General Hospital • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Medical records reveal clues to treating stubborn inflammatory bowel disease
Knowledge-focused CompletedThis study looks back at the medical records of over 1,000 people hospitalized with inflammatory bowel disease (IBD) in China. The goal is to understand the features, treatments, and outcomes of patients whose IBD does not respond well to standard therapies. By analyzing real-wor…
Sponsor: Shanghai 10th People's Hospital • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Brazilian IBD patients under the microscope: how long do they stay on treatment?
Knowledge-focused CompletedThis study observes 1006 adults with ulcerative colitis or Crohn's disease in Brazil who are taking or have taken vedolizumab. Researchers will look at how long patients stay on the drug and what other treatments they used before. No new treatment is given—this is just a review o…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
HIV drug side effects: new study probes liver damage risk
Knowledge-focused CompletedThis study looked at liver fibrosis (scarring) in 127 HIV patients who had high liver enzymes while on antiretroviral therapy. Participants underwent tests like liver biopsy, ultrasound, and CT scans to measure liver damage. The goal was to understand how common and severe liver …
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Could knowing the germs behind summer diarrhea in kids lead to better prevention?
Knowledge-focused CompletedThis study aims to find out which germs cause summer diarrhea in children who visit the emergency room. Researchers will collect stool samples from children aged 0 to 16 and test them for viruses, bacteria, and parasites. The goal is to better understand the causes of these infec…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Vitamin e study aims to uncover how body fat affects nutrient needs in women
Knowledge-focused CompletedThis completed Phase 1 study looked at how vitamin E is absorbed and used in the bodies of normal-weight and obese women, and whether vitamin C helps. Fifty women aged 18 to 40 took part, including some with type 2 diabetes. Researchers gave different doses of vitamin E (by mouth…
Phase: PHASE1 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Could a yellow tinge predict dangerous hospital infections?
Knowledge-focused CompletedThis study looks at whether jaundice, a yellowing of the skin and eyes, makes people with cirrhosis more likely to develop infections while in the hospital. Researchers will follow 250 Egyptian patients with cirrhosis to see if those with jaundice get more hospital-acquired infec…
Sponsor: Tanta University • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Gluten: friend or foe for elite athletes?
Knowledge-focused CompletedThis trial investigates whether gluten consumption affects digestive comfort, quality of life, and physical performance in non-celiac athletes who train intensively. Participants, who are healthy and free of digestive diseases, will be randomly assigned to a gluten-containing or …
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Could cannabis help fight diabetes? a study investigates
Knowledge-focused CompletedThis study explores whether compounds in cannabis, like THC and CBD, can reduce inflammation and improve how the body responds to insulin. Researchers will measure blood markers of inflammation and insulin sensitivity in people across the weight spectrum, both after a single use …
Sponsor: University of Colorado, Boulder • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Could common food additives be friend or foe? a massive study investigates
Knowledge-focused CompletedThis large observational study is investigating whether nitrate, nitrite, and phosphate—compounds found naturally in food and water and used as additives—are linked to chronic diseases like gastrointestinal cancers, heart disease, and respiratory conditions. Researchers will foll…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
AI nurses take on doctors in rural india trial
Knowledge-focused CompletedThis study tests whether nurses using an AI tool can plan care as well as doctors for common problems like high blood pressure, diabetes, fever, and shortness of breath. About 672 adults in rural and semi-urban India will see both a nurse with AI and a doctor, and their visits wi…
Phase: NA • Sponsor: Sarah Nabia • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Could your gut bacteria shape your mood after cancer surgery?
Knowledge-focused CompletedThis study looks at whether having certain E. coli bacteria in the colon after colorectal cancer surgery is linked to anxiety or depression. Researchers will compare psychiatric symptoms and diagnoses between patients who carry the bacteria and those who do not. The goal is to be…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Can a hidden patient reveal why cheap diarrhea treatment is underused?
Knowledge-focused CompletedThis trial investigates why many children with diarrhea do not receive oral rehydration salts (ORS), a simple and inexpensive treatment that can prevent most diarrhea-related deaths. Researchers will send anonymous standardized patients to private healthcare providers, posing as …
Phase: NA • Sponsor: RAND • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Pausing GLP-1 drugs before surgery: new study aims to find the sweet spot
Knowledge-focused CompletedThis study watches 186 adults who take GLP-1 drugs (like Ozempic) and are having planned surgery. Researchers use a stomach ultrasound to check how much food or liquid is left in the stomach after stopping the drug for different lengths of time. The goal is to see if longer pause…
Sponsor: Wonkwang University Hospital • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Fatty liver mystery: could how we process food be the key?
Knowledge-focused CompletedThis study looked at how people with and without non-alcoholic fatty liver disease (NAFLD) process food. Researchers monitored 53 adults over two days, measuring metabolism, blood, and urine after meals. The goal was to find differences that might explain why fat builds up in the…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Colonoscopy's carbon footprint under the microscope
Knowledge-focused CompletedThis study measures the carbon dioxide emissions produced during colonoscopy for colorectal cancer screening, including energy use, equipment, medications, and waste. Researchers will also compare different polypectomy techniques to see which are more eco-friendly. The goal is to…
Sponsor: King Chulalongkorn Memorial Hospital • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Study maps out tumor detection in rare stomach condition
Knowledge-focused CompletedThis completed study looked at how to best find and manage tumors in people with Zollinger-Ellison syndrome, a rare condition that causes too much stomach acid. Researchers used imaging tests and tissue samples to locate tumors and check for a related genetic condition called MEN…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Scientists pinpoint optimal sedation dose for safer gastroscopy across ages
Knowledge-focused CompletedThis study aims to find the 90% effective dose of tegileridine, a painkiller, when combined with propofol for sedation during painless gastroscopy. Researchers will test different doses in young (18-65) and elderly (65+) adults to see which dose best prevents movement, coughing, …
Phase: PHASE4 • Sponsor: Shiyou Wei • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Liver function may change how this drug works – new study recruiting
Knowledge-focused CompletedThis study looks at how the drug MK-1084 (calderasib) moves through the body in people with and without liver problems. Researchers will measure drug levels in the blood and check for side effects. About 58 adults will take a single dose and be monitored. The goal is to understan…
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Study checks if past drug still protects kidneys years later
Knowledge-focused CompletedThis study looks at American Indians with type 2 diabetes who had early kidney disease and took a drug called losartan years ago. Researchers want to see if the benefits of that treatment still help protect their kidneys today. About 141 people who were in the earlier study or th…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Small study aims to unlock secrets of rare lung disease
Knowledge-focused CompletedThis completed Phase 1 study looked at 27 people with and without pulmonary hypertension to learn more about how blood vessel problems contribute to the disease. Researchers used heart catheterization, imaging, and blood tests to find biomarkers and understand disease mechanisms.…
Phase: PHASE1 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Could gut microbes hold clues to autism symptoms?
Knowledge-focused CompletedThis study looks at how the gut microbiome and its chemical byproducts relate to gastrointestinal and behavioral symptoms in children with autism. By tracking 23 participants over time, researchers hope to identify biological markers that could one day help manage these symptoms.…
Sponsor: The Center for Discovery • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Spanish study hunts for hidden liver disease genes
Knowledge-focused CompletedThis study looks for genetic changes linked to progressive familial intrahepatic cholestasis (PFIC) in adults with unexplained bile flow problems. Researchers will collect health information and blood samples from 150 participants across Spain during a single visit. The goal is t…
Sponsor: Ipsen • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
NICU feeding study questions if 'Full Feed' means 'Full Skill'
Knowledge-focused CompletedThis study reviews the feeding skills of 100 infants discharged from a neonatal intensive care unit (NICU). Researchers want to know if an infant's ability to eat a full amount by mouth means they have fully developed feeding skills. They use a special tool called the SMART Tool …
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Dietary guidelines put to the test: does weight loss boost heart benefits?
Knowledge-focused CompletedThis study is testing whether following a Mediterranean-style diet based on U.S. dietary guidelines improves heart health more when combined with weight loss. Researchers will provide all meals for 70 adults with obesity or excess body fat for eight weeks. Participants will be sp…
Phase: NA • Sponsor: USDA, Western Human Nutrition Research Center • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Can tumor genetics predict survival in nasopharyngeal cancer?
Knowledge-focused CompletedThis study looks back at tissue samples from patients with nasopharyngeal carcinoma who took part in an earlier treatment trial. Researchers are using advanced genetic testing and protein analysis to look for markers linked to how long patients survive. The goal is to better unde…
Sponsor: Hellenic Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Does practice make perfect? a study probes how a Surgeon's learning curve impacts cancer surgery success
Knowledge-focused CompletedThis study looks at how a surgeon's growing experience with single-incision laparoscopic surgery—a minimally invasive technique using a single small cut—affects short- and long-term results for people with rectal or sigmoid colon cancer. By analyzing past cases from one surgical …
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Can fatty liver and hepatitis b together harm kidneys? a study digs into the data
Knowledge-focused CompletedThis study looks back at the medical records of 1,000 adults with both chronic hepatitis B and metabolic fatty liver disease. The goal is to understand how these conditions affect kidney function, especially in people on long-term antiviral therapy. Researchers will also examine …
Sponsor: Foshan Hospital of Traditional Chinese Medicine • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Could common hepatitis b drugs damage kidneys? a study digs into the data
Knowledge-focused CompletedThis study examines whether long-term use of antiviral drugs for chronic hepatitis B is linked to kidney problems in patients who also have non-alcoholic fatty liver disease. Researchers will analyze medical records from 300 patients to compare kidney function among those taking …
Sponsor: Foshan Hospital of Traditional Chinese Medicine • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Blood sugar swings after bariatric surgery may forecast baby size
Knowledge-focused CompletedWomen who become pregnant after weight-loss (bariatric) surgery have a higher chance of delivering smaller-than-expected babies. This study tests whether tracking blood sugar fluctuations with a continuous glucose monitor during each trimester can help predict which babies will b…
Phase: NA • Sponsor: Centro Hospitalar Universitário de Santo António • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Could hepatitis e be hiding in transplant patients? a screening study aims to find out.
Knowledge-focused CompletedHepatitis E can cause severe liver problems in people who have had an organ transplant, and may become chronic. This study screens liver and kidney transplant patients in Guadeloupe using blood tests to measure how many carry the virus. The goal is to learn whether routine screen…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de la Guadeloupe • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Can type 1 diabetes hold kids back from being fit and active? a study aims to find out.
Knowledge-focused CompletedThis study looks at how type 1 diabetes affects the heart, lungs, and overall fitness of children aged 6 to 17. It also measures their physical activity levels and quality of life. Researchers will compare these results with those of healthy children of the same age. The goal is …
Sponsor: Institut Saint Pierre • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Protein shake vs. gut trouble: can whey help athletes digest fructose after heat stress?
Knowledge-focused CompletedThis pilot study tests whether a multi-ingredient whey supplement can reduce fructose malabsorption in healthy adults after hiking under heat stress. Eight participants will consume fructose and have their breath hydrogen measured as a marker of malabsorption, both before and aft…
Phase: NA • Sponsor: Arizona State University • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Can we predict who will survive a bowel surgery leak?
Knowledge-focused CompletedThis study looks at people who develop a leak after colorectal cancer surgery. Researchers will track which patients need emergency surgery, die within 90 days, or end up with a permanent stoma. The goal is to find factors that predict these outcomes and help guide future care.
Sponsor: Alexandria University • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Can a quick MRI scan reveal what a healthy Child's liver looks like?
Knowledge-focused CompletedThis study aims to determine normal liver stiffness values in healthy children aged 7 to 17 using a special MRI technique called MR elastography. Participants receive a one-time research MRI and a blood draw to confirm their liver is healthy. The results could help doctors better…
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Can a single Protein's mutations predict esophageal cancer outcomes?
Knowledge-focused CompletedThis study examines 300 esophageal cancer tissue and blood samples to classify tumors based on p53 gene mutations, protein expression, and immune response. Researchers will link these molecular subtypes to patient survival and treatment patterns. The goal is to see whether p53 fe…
Sponsor: Ling Zhiqiang • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Smartwatch AI may predict liver crisis before symptoms start
Knowledge-focused CompletedThis study tests whether an Apple Watch, combined with artificial intelligence, can detect early signs of improvement or deterioration in people with advanced chronic liver disease (cirrhosis). Participants wear the watch to continuously track heart rate, oxygen levels, sleep, ac…
Sponsor: Antonio Galante • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Nerve system glitches may worsen blood pressure swings during achalasia surgery — a study investigates
Knowledge-focused CompletedThis study looks at whether achalasia patients with autonomic (involuntary) nerve system problems experience more blood pressure instability during a procedure called per-oral endoscopic myotomy (POEM) under general anesthesia. Researchers will test nerve function before surgery …
Sponsor: Gangnam Severance Hospital • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
One simple score to rate colorectal cancer surgery quality?
Knowledge-focused CompletedThis large Italian study investigates whether a composite measure called 'Textbook Outcome' can serve as a reliable indicator of quality in colorectal cancer surgery. Researchers will analyze data from over 6,000 patients to see if meeting six key criteria—including survival, com…
Sponsor: Academy of Applied Medical and Social Sciences, Poland • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Can a tumor-zapping procedure also wake up the immune system?
Knowledge-focused CompletedThis study looks at how two heat-based procedures — radiofrequency ablation and microwave ablation — affect the immune system in people with small liver cancers. Researchers will take blood samples and tissue biopsies before and after treatment to track changes in immune cells. T…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Which appendix surgery causes fewer blockages? a Head-to-Head comparison
Knowledge-focused CompletedThis study compares how often bowel obstruction occurs after two types of appendix removal surgery: open appendectomy and laparoscopic appendectomy. Fifty people with acute appendicitis will be randomly assigned to one of the two procedures. The goal is to see whether the minimal…
Phase: NA • Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Scientists hunt for hidden fat molecules that sabotage insulin
Knowledge-focused CompletedThis study investigates how specific fat molecules called diacylglycerols and sphingolipids inside muscle cells influence insulin resistance. Researchers will measure these lipids in different parts of muscle cells before and after weight loss or exercise in people with obesity, …
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New model could spot dangerous surgical leaks before they happen
Knowledge-focused CompletedThis study aims to create a simple model that uses routine clinical and lab data from the first day after colorectal cancer surgery to predict the risk of anastomotic leakage—a serious complication where the surgical connection leaks. Researchers reviewed records of 117 patients …
Sponsor: University of Foggia • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Massive study aims to map hepatitis c elimination in pakistan
Knowledge-focused CompletedThis large study in Pakistan tracks 25,000 adults with hepatitis C to see how well current government-sponsored treatments work and whether the virus develops resistance. Researchers will measure cure rates, new infections, and reinfections over time. The goal is to find the best…
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Ultrasound inside the body reveals how tumors block the bile duct
Knowledge-focused CompletedThis study uses endoscopic ultrasound—a tiny ultrasound probe on a flexible tube passed through the mouth—to measure the size of the common bile duct in people with jaundice caused by pancreatic or bile duct tumors. Researchers aim to better understand how these tumors compress t…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Weight-Loss drugs may offer early liver protection, study suggests
Knowledge-focused CompletedThis study looks at whether two popular weight-loss medications, semaglutide and tirzepatide, can improve early signs of liver damage in people with overweight or obesity. Researchers measured changes in liver health markers after at least 12 weeks of treatment in 154 adults. The…
Sponsor: Goztepe Prof Dr Suleyman Yalcın City Hospital • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Could more surgery and radiation after immunotherapy keep esophageal cancer at bay?
Knowledge-focused CompletedThis study looks back at medical records of people with esophageal squamous cell carcinoma who had immunotherapy and chemotherapy before surgery, followed by complete tumor removal. The goal is to see if adding radiotherapy after surgery, and how many lymph nodes were removed, af…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Rural health revolution: training future doctors and PAs to collaborate
Knowledge-focused CompletedThis study tests a two-year educational program for medical and physician assistant students in rural areas. The curriculum includes classroom sessions, simulations, and community rotations to improve teamwork skills. Researchers measure changes in knowledge, attitudes, and team …
Phase: NA • Sponsor: Pacific Northwest University of Health Sciences • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Blood-Clotting showdown: which device best guides bleeding care in High-Risk patients?
Knowledge-focused CompletedThis study compares three devices that measure how well blood clots — ClotPro, ROTEM, and TEG — in patients undergoing liver surgery, neurosurgery, or cesarean section. The goal is to see how closely the results from these devices agree with each other. The findings may help doct…
Sponsor: Medical University of Vienna • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Liver function may change how mavorixafor works in the body
Knowledge-focused CompletedThis study investigates how a single dose of mavorixafor is processed in people with mild to moderate liver impairment compared to healthy volunteers with normal liver function. Researchers will measure drug levels in the blood and monitor safety and tolerability. The goal is to …
Phase: PHASE1 • Sponsor: X4 Pharmaceuticals • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Liver function may change how belapectin works in the body
Knowledge-focused CompletedThis study looks at how the drug belapectin moves through the body in people with mild, moderate, or severe liver impairment compared to healthy volunteers. Participants receive a single intravenous dose, and researchers measure drug levels in the blood over time. The goal is to …
Phase: PHASE1 • Sponsor: Galectin Therapeutics Inc. • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Computer tool aims to personalize colon cancer screening for the uninsured
Knowledge-focused CompletedThis study tests a computerized tool that collects patient information and generates personalized, guideline-based next steps for colorectal cancer screening. It focuses on a large, diverse population of under- and uninsured patients in Dallas. The goal is to improve screening ra…
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Artificial intelligence could help guide liver cancer treatment after surgery
Knowledge-focused CompletedThis study developed an artificial intelligence model that analyzes MRI scans and pathology images to predict the risk of liver cancer returning after surgery. Researchers used data from over 500 patients who had their liver cancer surgically removed. The goal is to help doctors …
Sponsor: Anhui Provincial Hospital • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Oxygen mapping in pancreatic tumors could reveal hidden clues to aggressive cancer
Knowledge-focused CompletedThis study investigates low-oxygen (hypoxic) areas within pancreatic tumors by giving patients a special marker before surgery. The marker highlights oxygen-deprived regions in the removed tumor tissue. Researchers will then analyze how these hypoxic zones relate to patient survi…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Physiotherapy after liver transplant may boost long-term physical and mental function
Knowledge-focused CompletedThis study looks at whether participating in a routine physiotherapy program after a liver transplant leads to better physical and cognitive outcomes about a year later. Researchers compared liver transplant recipients who did physiotherapy with those who did not, measuring balan…
Sponsor: Hasan Kalyoncu University • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
New risk score aims to predict which pancreatic tumors will return after surgery
Knowledge-focused CompletedThis study aims to create a simple risk score to identify patients with pancreatic neuroendocrine tumors (PanNETs) who are at high risk of their cancer returning after surgery. Current methods are not very good at predicting individual risk. Researchers will analyze data from ove…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Menstrual cycle forces women with diabetes to hack their insulin pumps
Knowledge-focused CompletedThis study investigates how women with type 1 diabetes manually adjust their automated insulin delivery (AID) systems to manage blood sugar changes during their menstrual cycle. Researchers will interview 69 women to catalog strategies like entering fake carbohydrates or changing…
Sponsor: DCB Research AG • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Gut bacteria clues could help predict dangerous bowel disease in preemies
Knowledge-focused CompletedThis study looks at the gut bacteria of premature babies to see if differences exist between those who develop necrotizing enterocolitis (NEC) — a severe bowel condition — and those who do not. Researchers collect weekly blood and daily stool samples from about 300 premature infa…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Heart safety check for hepatitis b drug candidate
Knowledge-focused CompletedThis study investigates whether a single dose of bepirovirsen, a potential treatment for hepatitis B, affects the heart's electrical activity. Healthy adults aged 18 to 55 receive either the drug or a placebo, and their heart rhythms are monitored continuously by ECG. The goal is…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Blood markers may reveal who is at risk from severe abdominal infections
Knowledge-focused CompletedThis study looks at whether certain immune checkpoint molecules found in the blood can help predict how serious an intra-abdominal infection is and the risk of death. Researchers will measure 10 different molecules in 75 patients with these infections. The goal is to better under…
Sponsor: Istanbul Training and Research Hospital • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Gum disease may alter key hormone and oxidative markers in diabetes patients
Knowledge-focused CompletedThis observational study investigates how different levels of gum health influence asprosin (a hormone) and total oxidant/antioxidant levels in people with type 2 diabetes. Researchers will collect fluid from around the gums and blood samples from 67 participants to compare these…
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Blood scores may identify low-risk patients after hepatitis c cure, reducing need for lifelong cancer scans
Knowledge-focused CompletedThis study looks at whether simple, non-invasive blood test scores can predict the risk of developing liver cancer in people with advanced liver disease who have been cured of hepatitis C. Researchers analyzed data from 571 adults treated at a single hospital over ten years. The …
Sponsor: Siriraj Hospital • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Could skipping random biopsies during colonoscopy be just as safe for IBD patients?
Knowledge-focused CompletedThis study compares two ways of doing colonoscopy in people with inflammatory bowel disease (IBD) who are at higher risk for colon cancer. One method takes biopsies only from visible abnormal areas, while the other also takes random biopsies from normal-looking tissue. The goal i…
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
AI may solve tricky liver diagnosis puzzle
Knowledge-focused CompletedThis study tests whether artificial intelligence can help doctors tell the difference between drug-induced liver injury and autoimmune hepatitis, two conditions that look very similar. Researchers are building a machine learning model using data from over 2,500 patients. If it wo…
Sponsor: Beijing Friendship Hospital • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
New study aims to pinpoint hidden cause of chronic constipation
Knowledge-focused CompletedThis study looks at people with chronic constipation to see if a specific muscle problem called puborectalis syndrome can be better identified using three different tests: defecography, high-resolution anorectal manometry, and pelvic floor ultrasound. Researchers will compare res…
Sponsor: Third Military Medical University • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Liver's Post-Meal secrets could unlock new fatty liver treatments
Knowledge-focused CompletedThis study investigates how the liver processes nutrients after a meal in healthy individuals and in patients with fatty liver disease or cirrhosis. Researchers will take blood samples and liver biopsies after fasting or eating a standardized meal, and after a glucagon injection.…
Phase: NA • Sponsor: Copenhagen University Hospital, Hvidovre • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC